No retraction, correction or concern found when last checked on Oct 22, 2026.

Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation

Vaishali Chugh, K. Vijaya Krishna, Abhay Pandit

ACS Nano · 2021 · Review · CC BY

Abstract

Cell membrane-coated (CMC) mimics are micro/nanosystems that combine an isolated cell membrane and a template of choice to mimic the functions of a cell. The design exploits its physicochemical and biological properties for therapeutic applications. The mimics demonstrate excellent biological compatibility, enhanced biointerfacing capabilities, physical, chemical, and biological tunability, ability to retain cellular properties, immune escape, prolonged circulation time, and protect the encapsulated drug from degradation and active targeting. These properties and the ease of adapting them for personalized clinical medicine have generated a significant research interest over the past decade. This review presents a detailed overview of the recent advances in the development of cell membrane-coated (CMC) mimics. The primary focus is to collate and discuss components, fabrication methodologies, and the significance of physiochemical and biological characterization techniques for validating a CMC mimic. We present a critical analysis of the two main components of CMC mimics: the template and the cell membrane and mapped their use in therapeutic scenarios. In addition, we have emphasized on the challenges associated with CMC mimics in their clinical translation. Overall, this review is an up to date toolbox that researchers can benefit from while designing and characterizing CMC mimics.

References 415

1.
Latourte A.; Kloppenburg M.; Richette P. Emerging Pharmaceutical Therapies for Osteoarthritis. Nat. Rev. Rheumatol. 2020, 16, 673–688..
Not in our library10.1038/s41584-020-00518-6
2.
Sanders J. M.; Monogue M. L.; Jodlowski T. Z.; Cutrell J. B. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. J. Am. Med. Assoc. 2020, 323, 1824–1836..
Not in our library10.1001/jama.2020.6019
3.
Sahin U.; Kariko K.; Tureci O. mRNA-Based Therapeutics-Developing a New Class of Drugs. Nat. Rev. Drug Discovery 2014, 13, 759–780..
Not in our library10.1038/nrd4278
4.
Van de Glind E. M.; Van Enst W. A.; Van Munster B. C.; Olde Rikkert M. G.; Scheltens P.; Scholten R. J.; Hooft L. Pharmacological Treatment of Dementia: A Scoping Review of Systematic Reviews. Dementia Geriatr. Cognit. Disord. 2013, 36, 211–228..
Not in our library10.1159/000353892
5.
Talsky A.; Pacione L. R.; Shaw T.; Wasserman L.; Lenny A. M.; Verma A.; Hurwitz G.; Waxman R.; Morgan A.; Bhalerao S. Pharmacological Interventions for Traumatic Brain Injury. B. C. Med. J. 2011, 53, 26–31.
Not in our library
6.
Sartori S. B.; Singewald N. Novel Pharmacological Targets in Drug Development for the Treatment of Anxiety and Anxiety-Related Disorders. Pharmacol. Ther. 2019, 204, 107402–107434..
Not in our library10.1016/j.pharmthera.2019.107402
7.
Chidambaram M.; Manavalan R.; Kathiresan K. Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations. J. Pharm. Pharm. Sci. 2011, 14, 67–77..
Not in our library10.18433/j30c7d
8.
Veiseh O.; Tang B. C.; Whitehead K. A.; Anderson D. G.; Langer R. Managing Diabetes with Nanomedicine: Challenges and Opportunities. Nat. Rev. Drug Discovery 2015, 14, 45–57..
Not in our library10.1038/nrd4477
9.
Nel A. E. Transformational Impact of Nanomedicine: Reconciling Outcome with Promise. Nano Lett. 2020, 20, 5601–5603..
Not in our library10.1021/acs.nanolett.0c02738
10.
Hadjidemetriou M.; Kostarelos K. Nanomedicine: Evolution of the Nanoparticle Corona. Nat. Nanotechnol. 2017, 12, 288–290..
Not in our library10.1038/nnano.2017.61
11.
Cai P.; Zhang X.; Wang M.; Wu Y. L.; Chen X. Combinatorial Nano-Bio Interfaces. ACS Nano 2018, 12, 5078–5084..
Not in our library10.1021/acsnano.8b03285
12.
Nienhaus K.; Wang H.; Nienhaus G. U. Nanoparticles for Biomedical Applications: Exploring and Exploiting Molecular Interactions at the Nano-Bio Interface. Mater. Today Adv. 2020, 5, 100036–100055..
Not in our library10.1016/j.mtadv.2019.100036
13.
Mura S.; Nicolas J.; Couvreur P. Stimuli-Responsive Nanocarriers for Drug Delivery. Nat. Mater. 2013, 12, 991–1003..
Not in our library10.1038/nmat3776
14.
Karimi M.; Ghasemi A.; Sahandi Zangabad P.; Rahighi R.; Moosavi Basri S. M.; Mirshekari H.; Amiri M.; Shafaei Pishabad Z.; Aslani A.; Bozorgomid M.; Ghosh D.; Beyzavi A.; Vaseghi A.; Aref A. R.; Haghani L.; Bahrami S.; Hamblin M. R. Smart Micro/Nanoparticles in Stimulus-Responsive Drug/Gene Delivery Systems. Chem. Soc. Rev. 2016, 45, 1457–1501..
Not in our library10.1039/c5cs00798d
15.
Parodi A.; Molinaro R.; Sushnitha M.; Evangelopoulos M.; Martinez J. O.; Arrighetti N.; Corbo C.; Tasciotti E. Bio-Inspired Engineering of Cell and Virus-Like Nanoparticles for Drug Delivery. Biomaterials 2017, 147, 155–168..
Not in our library10.1016/j.biomaterials.2017.09.020
16.
Moncalvo F.; Martinez Espinoza M. I.; Cellesi F. Nanosized Delivery Systems for Therapeutic Proteins: Clinically Validated Technologies and Advanced Development Strategies. Front. Bioeng. Biotechnol. 2020, 8, 89.
Not in our library10.3389/fbioe.2020.00089
17.
Stealth Coating of Nanoparticles in Drug-Delivery Systems · 2020
No notice
18.
Targeted Intracellular Delivery of Antibodies: The State of the Art · 2018
No notice
19.
Targeted drug delivery for cancer therapy: the other side of antibodies · 2012
No notice
20.
Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy · 2020
No notice
21.
Guan B.; Zhang X. Aptamers As Versatile Ligands for Biomedical and Pharmaceutical Applications. Int. J. Nanomed. 2020, 15, 1059–1071..
Not in our library10.2147/ijn.s237544
22.
Lian Z.; Ji T. Functional Peptide-Based Drug Delivery Systems. J. Mater. Chem. B 2020, 8, 6517–6529..
Not in our library10.1039/d0tb00713g
23.
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies · 2020
No notice
24.
Zhuang C.; Guan X.; Ma H.; Cong H.; Zhang W.; Miao Z. Small Molecule-Drug Conjugates: A Novel Strategy for Cancer-Targeted Treatment. Eur. J. Med. Chem. 2019, 163, 883–895..
Not in our library10.1016/j.ejmech.2018.12.035
25.
Ekladious I.; Colson Y. L.; Grinstaff M. W. Polymer-Drug Conjugate Therapeutics: Advances, Insights and Prospects. Nat. Rev. Drug Discovery 2019, 18, 273–294..
Not in our library10.1038/s41573-018-0005-0
26.
Merkel T. J.; Jones S. W.; Herlihy K. P.; Kersey F. R.; Shields A. R.; Napier M.; Luft J. C.; Wu H.; Zamboni W. C.; Wang A. Z.; Bear J. E.; DeSimone J. M. Using Mechanobiological Mimicry of Red Blood Cells to Extend Circulation Times of Hydrogel Microparticles. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 586–591..
Not in our library10.1073/pnas.1010013108
27.
Palange A. L.; Palomba R.; Rizzuti I. F.; Ferreira M.; Decuzzi P. Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents. Mol. Ther. 2017, 25, 1514–1521..
Not in our library10.1016/j.ymthe.2017.02.012
28.
Schoonen L.; van Hest J. C. Compartmentalization Approaches in Soft Matter Science: From Nanoreactor Development to Organelle Mimics. Adv. Mater. 2016, 28, 1109–1128..
Not in our library10.1002/adma.201502389
29.
Mason A. F.; Yewdall N. A.; Welzen P. L. W.; Shao J.; van Stevendaal M.; van Hest J. C. M.; Williams D. S.; Abdelmohsen L. Mimicking Cellular Compartmentalization in a Hierarchical Protocell through Spontaneous Spatial Organization. ACS Cent. Sci. 2019, 5, 1360–1365..
Not in our library10.1021/acscentsci.9b00345
30.
Balasubramanian V.; Poillucci A.; Correia A.; Zhang H.; Celia C.; Santos H. A. Cell Membrane-Based Nanoreactor to Mimic the Bio-Compartmentalization Strategy of a Cell. ACS Biomater. Sci. Eng. 2018, 4, 1471–1478..
Not in our library10.1021/acsbiomaterials.7b00944
31.
Zhang X.; Tanner P.; Graff A.; Palivan C. G.; Meier W. Mimicking the Cell Membrane with Block Copolymer Membranes. J. Polym. Sci., Part A: Polym. Chem. 2012, 50, 2293–2318..
Not in our library10.1002/pola.26000
32.
Peetla C.; Stine A.; Labhasetwar V. Biophysical Interactions with Model Lipid Membranes: Applications in Drug Discovery and Drug Delivery. Mol. Pharmaceutics 2009, 6, 1264–1276..
Not in our library10.1021/mp9000662
33.
Lo C.; Bhardwaj K.; Marculescu R. Towards Cell-Based Therapeutics: A Bio-Inspired Autonomous Drug Delivery System. Nano Commun. Netw 2017, 12, 25–33..
Not in our library10.1016/j.nancom.2017.01.006
34.
Petrenko V. A. Autonomous Self-Navigating Drug-Delivery Vehicles: From Science Fiction to Reality. Ther. Delivery 2017, 8, 1063–1107..
Not in our library10.4155/tde-2017-0086
35.
Large D. E.; Soucy J. R.; Hebert J.; Auguste D. T. Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery. Adv. Therap. 2019, 2, 1800091–1800117..
Not in our library10.1002/adtp.201800091
36.
Karimi M.; Sahandi Zangabad P.; Baghaee-Ravari S.; Ghazadeh M.; Mirshekari H.; Hamblin M. R. Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light. J. Am. Chem. Soc. 2017, 139, 4584–4610..
Not in our library10.1021/jacs.6b08313
37.
Chowdhury A.; Kunjiappan S.; Panneerselvam T.; Somasundaram B.; Bhattacharjee C. Nanotechnology and Nanocarrier-Based Approaches on Treatment of Degenerative Diseases. Int. Nano Lett. 2017, 7, 91–122..
Not in our library10.1007/s40089-017-0208-0
38.
Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation · 2018
No notice
39.
Dimov N.; Kastner E.; Hussain M.; Perrie Y.; Szita N. Formation and Purification of Tailored Liposomes for Drug Delivery Using a Module-Based Micro Continuous-Flow System. Sci. Rep. 2017, 7, 12045–12057..
Not in our library10.1038/s41598-017-11533-1
40.
Gothwal A.; Khan I.; Gupta U. Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs. Pharm. Res. 2016, 33, 18–39..
Not in our library10.1007/s11095-015-1784-1
41.
Moller A.; Lobb R. J. The Evolving Translational Potential of Small Extracellular Vesicles in Cancer. Nat. Rev. Cancer 2020, 20, 697–709..
Not in our library10.1038/s41568-020-00299-w
42.
Liposomal Formulations in Clinical Use: An Updated Review · 2017
No notice
43.
Varela-Moreira A.; Shi Y.; Fens M. H. A. M.; Lammers T.; Hennink W. E.; Schiffelers R. M. Clinical Application of Polymeric Micelles for the Treatment of Cancer. Mater. Chem. Front. 2017, 1, 1485–1501..
Not in our library10.1039/c6qm00289g
44.
Toh M.-R.; Chiu G. N. C. Liposomes As Sterile Preparations and Limitations of Sterilisation Techniques in Liposomal Manufacturing. Asian J. Pharm. Sci. 2013, 8, 88–95..
Not in our library10.1016/j.ajps.2013.07.011
45.
Harrell C. R.; Djonov V.; Fellabaum C.; Volarevic V. Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin. Int. J. Med. Sci. 2018, 15, 274–279..
Not in our library10.7150/ijms.22644
46.
Tapia-Guerrero Y. S.; Del Prado-Audelo M. L.; Borbolla-Jimenez F. V.; Giraldo Gomez D. M.; Garcia-Aguirre I.; Colin-Castro C. A.; Morales-Gonzalez J. A.; Leyva-Gomez G.; Magana J. J. Effect of UV and Gamma Irradiation Sterilization Processes in the Properties of Different Polymeric Nanoparticles for Biomedical Applications. Materials 2020, 13, 1090–1108..
Not in our library10.3390/ma13051090
47.
Kalluri R.; LeBleu V. S. The Biology, Function, and Biomedical Applications of Exosomes. Science 2020, 367, eaau6977.
Not in our library10.1126/science.aau6977
48.
Klyachko N. L.; Arzt C. J.; Li S. M.; Gololobova O. A.; Batrakova E. V. Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations. Pharmaceutics 2020, 12, 1171–1196..
Not in our library10.3390/pharmaceutics12121171
49.
Villa F.; Quarto R.; Tasso R. Extracellular Vesicles As Natural, Safe and Efficient Drug Delivery Systems. Pharmaceutics 2019, 11, 557–562..
Not in our library10.3390/pharmaceutics11110557
50.
Burgio S.; Noori L.; Marino Gammazza A.; Campanella C.; Logozzi M.; Fais S.; Bucchieri F.; Cappello F.; Caruso Bavisotto C. Extracellular Vesicles-Based Drug Delivery Systems: A New Challenge and the Exemplum of Malignant Pleural Mesothelioma. Int. J. Mol. Sci. 2020, 21, 5432–5460..
Not in our library10.3390/ijms21155432
51.
Whitford W.; Guterstam P. Exosome Manufacturing Status. Future Med. Chem. 2019, 11, 1225–1236..
Not in our library10.4155/fmc-2018-0417
52.
Yang M.; Wu S. Y. The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics. Front. Pharmacol. 2018, 9, 735–739..
Not in our library10.3389/fphar.2018.00735
53.
Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source · 2020
No notice
54.
Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications · 2019
No notice
55.
Kang T.; Zhu Q.; Wei D.; Feng J.; Yao J.; Jiang T.; Song Q.; Wei X.; Chen H.; Gao X.; Chen J. Nanoparticles Coated with Neutrophil Membranes can Effectively Treat Cancer Metastasis. ACS Nano 2017, 11, 1397–1411..
Not in our library10.1021/acsnano.6b06477
56.
Piao J.-G.; Wang L.; Gao F.; You Y.-Z.; Xiong Y.; Yang L. Erythrocyte Membrane is an Alternative Coating to Polyethylene Glycol for Prolonging the Circulation Lifetime of Gold Nanocages for Photothermal Therapy. ACS Nano 2014, 8, 10414–10425..
Not in our library10.1021/nn503779d
57.
Rao L.; Cai B.; Bu L. L.; Liao Q. Q.; Guo S. S.; Zhao X. Z.; Dong W. F.; Liu W. Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. ACS Nano 2017, 11, 3496–3505..
Not in our library10.1021/acsnano.7b00133
58.
Shao J.; Pijpers I. A. B.; Cao S.; Williams D. S.; Yan X.; Li J.; Abdelmohsen L.; van Hest J. C. M. Biomorphic Engineering of Multifunctional Polylactide Stomatocytes toward Therapeutic Nano-Red Blood Cells. Adv. Sci. 2019, 6, 1801678–1801685..
Not in our library10.1002/advs.201801678
59.
Camouflaging bacteria by wrapping with cell membranes · 2019
Corrected
60.
Liang X.; Ye X.; Wang C.; Xing C.; Miao Q.; Xie Z.; Chen X.; Zhang X.; Zhang H.; Mei L. Photothermal Cancer Immunotherapy by Erythrocyte Membrane-Coated Black Phosphorus Formulation. J. Controlled Release 2019, 296, 150–161..
Not in our library10.1016/j.jconrel.2019.01.027
61.
Xuan M.; Shao J.; Zhao J.; Li Q.; Dai L.; Li J. Magnetic Mesoporous Silica Nanoparticles Cloaked by Red Blood Cell Membranes: Applications in Cancer Therapy. Angew. Chem., Int. Ed. 2018, 57, 6049–6053..
Not in our library10.1002/anie.201712996
62.
Hu C. M.; Zhang L.; Aryal S.; Cheung C.; Fang R. H.; Zhang L. Erythrocyte Membrane-Camouflaged Polymeric Nanoparticles As a Biomimetic Delivery Platform. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 10980–10985..
Not in our library10.1073/pnas.1106634108
63.
Parodi A.; Quattrocchi N.; van de Ven A. L.; Chiappini C.; Evangelopoulos M.; Martinez J. O.; Brown B. S.; Khaled S. Z.; Yazdi I. K.; Enzo M. V.; Isenhart L.; Ferrari M.; Tasciotti E. Synthetic Nanoparticles Functionalized with Biomimetic Leukocyte Membranes Possess Cell-Like Functions. Nat. Nanotechnol. 2013, 8, 61–68..
Not in our library10.1038/nnano.2012.212
64.
Li L. L.; Xu J. H.; Qi G. B.; Zhao X.; Yu F.; Wang H. Core-Shell Supramolecular Gelatin Nanoparticles for Adaptive and “On-Demand” Antibiotic Delivery. ACS Nano 2014, 8, 4975–4983..
Not in our library10.1021/nn501040h
65.
Chen Z.; Zhao P.; Luo Z.; Zheng M.; Tian H.; Gong P.; Gao G.; Pan H.; Liu L.; Ma A.; Cui H.; Ma Y.; Cai L. Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy. ACS Nano 2016, 10, 10049–10057..
Not in our library10.1021/acsnano.6b04695
66.
Zhang Q.; Dehaini D.; Zhang Y.; Zhou J.; Chen X.; Zhang L.; Fang R. H.; Gao W.; Zhang L. Neutrophil Membrane-Coated Nanoparticles Inhibit Synovial Inflammation and Alleviate Joint Damage in Inflammatory Arthritis. Nat. Nanotechnol. 2018, 13, 1182–1190..
Not in our library10.1038/s41565-018-0254-4
67.
Pitchaimani A.; Nguyen T. D. T.; Marasini R.; Eliyapura A.; Azizi T.; Jaberi-Douraki M.; Aryal S. Biomimetic Natural Killer Membrane Camouflaged Polymeric Nanoparticle for Targeted Bioimaging. Adv. Funct. Mater. 2019, 29, 1806817–1806827..
Not in our library10.1002/adfm.201806817
68.
Liu J. M.; Zhang D. D.; Fang G. Z.; Wang S. Erythrocyte Membrane Bioinspired Near-Infrared Persistent Luminescence Nanocarriers for in Vivo Long-Circulating Bioimaging and Drug Delivery. Biomaterials 2018, 165, 39–47..
Not in our library10.1016/j.biomaterials.2018.02.042
69.
Xuan M.; Shao J.; Dai L.; He Q.; Li J. Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for in Vivo Cancer Therapy. Adv. Healthcare Mater. 2015, 4, 1645–1652..
Not in our library10.1002/adhm.201500129
70.
Zuo H.; Tao J.; Shi H.; He J.; Zhou Z.; Zhang C. Platelet-Mimicking Nanoparticles Co-Loaded with W18O49 and Metformin Alleviate Tumor Hypoxia for Enhanced Photodynamic Therapy and Photothermal Therapy. Acta Biomater. 2018, 80, 296–307..
Not in our library10.1016/j.actbio.2018.09.017
71.
Nguyen T. D. T.; Marasini R.; Rayamajhi S.; Aparicio C.; Biller D.; Aryal S. Erythrocyte Membrane Concealed Paramagnetic Polymeric Nanoparticle for Contrast-Enhanced Magnetic Resonance Imaging. Nanoscale 2020, 12, 4137–4149..
Not in our library10.1039/d0nr00039f
72.
Li Y. J.; Yang C. X.; Yan X. P. Biomimetic Persistent Luminescent Nanoplatform for Autofluorescence-Free Metastasis Tracking and Chemophotodynamic Therapy. Anal. Chem. 2018, 90, 4188–4195..
Not in our library10.1021/acs.analchem.8b00311
73.
Zhu J. Y.; Zheng D. W.; Zhang M. K.; Yu W. Y.; Qiu W. X.; Hu J. J.; Feng J.; Zhang X. Z. Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes. Nano Lett. 2016, 16, 5895–5901..
Not in our library10.1021/acs.nanolett.6b02786
74.
Chen H. W.; Fang Z. S.; Chen Y. T.; Chen Y. I.; Yao B. Y.; Cheng J. Y.; Chien C. Y.; Chang Y. C.; Hu C. J. Targeting and Enrichment of Viral Pathogen by Cell Membrane Cloaked Magnetic Nanoparticles for Enhanced Detection. ACS Appl. Mater. Interfaces 2017, 9, 39953–39961..
Not in our library10.1021/acsami.7b09931
75.
Gong H.; Chen F.; Huang Z.; Gu Y.; Zhang Q.; Chen Y.; Zhang Y.; Zhuang J.; Cho Y. K.; Fang R. H.; Gao W.; Xu S.; Zhang L. Biomembrane-Modified Field Effect Transistors for Sensitive and Quantitative Detection of Biological Toxins and Pathogens. ACS Nano 2019, 13, 3714–3722..
Not in our library10.1021/acsnano.9b00911
76.
Wu Z.; Li J.; de Ávila B. E.-F.; Li T.; Gao W.; He Q.; Zhang L.; Wang J. Water-Powered Cell-Mimicking Janus Micromotor. Adv. Funct. Mater. 2015, 25, 7497–7501..
Not in our library10.1002/adfm.201503441
77.
Chen Y.; Zhang Y.; Zhuang J.; Lee J. H.; Wang L.; Fang R. H.; Gao W.; Zhang L. Cell-Membrane-Cloaked Oil Nanosponges Enable Dual-Modal Detoxification. ACS Nano 2019, 13, 7209–7215..
Not in our library10.1021/acsnano.9b02773
78.
Ouyang J.; Wang L.; Chen W.; Zeng K.; Han Y.; Xu Y.; Xu Q.; Deng L.; Liu Y. N. Biomimetic Nanothylakoids for Efficient Imaging-Guided Photodynamic Therapy for Cancer. Chem. Commun. (Cambridge, U. K.) 2018, 54, 3468–3471..
Not in our library10.1039/c8cc00674a
79.
Pei Q.; Hu X.; Zheng X.; Liu S.; Li Y.; Jing X.; Xie Z. Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy. ACS Nano 2018, 12, 1630–1641..
Not in our library10.1021/acsnano.7b08219
80.
Goni F. M. The Basic Structure and Dynamics of Cell Membranes: An Update of the Singer-Nicolson Model. Biochim. Biophys. Acta, Biomembr. 2014, 1838, 1467–1476..
Not in our library10.1016/j.bbamem.2014.01.006
81.
There Is No Simple Model of the Plasma Membrane Organization · 2016
No notice
82.
Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues · 2019
No notice
83.
Bucior I.; Scheuring S.; Engel A.; Burger M. M. Carbohydrate-Carbohydrate Interaction Provides Adhesion Force and Specificity for Cellular Recognition. J. Cell Biol. 2004, 165, 529–537..
Not in our library10.1083/jcb.200309005
84.
Bucior I.; Burger M. M. Carbohydrate-Carbohydrate Interactions in Cell Recognition. Curr. Opin. Struct. Biol. 2004, 14, 631–637..
Not in our library10.1016/j.sbi.2004.08.006
85.
Simons K.; Vaz W. L. Model Systems, Lipid Rafts, and Cell Membranes. Annu. Rev. Biophys. Biomol. Struct. 2004, 33, 269–295..
Not in our library10.1146/annurev.biophys.32.110601.141803
86.
Liang H.; Huang K.; Su T.; Li Z.; Hu S.; Dinh P. U.; Wrona E. A.; Shao C.; Qiao L.; Vandergriff A. C.; Hensley M. T.; Cores J.; Allen T.; Zhang H.; Zeng Q.; Xing J.; Freytes D. O.; Shen D.; Yu Z.; Cheng K. Mesenchymal Stem Cell/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure. ACS Nano 2018, 12, 6536–6544..
Not in our library10.1021/acsnano.8b00553
87.
Ye H.; Wang K.; Wang M.; Liu R.; Song H.; Li N.; Lu Q.; Zhang W.; Du Y.; Yang W.; Zhong L.; Wang Y.; Yu B.; Wang H.; Kan Q.; Zhang H.; Wang Y.; He Z.; Sun J. Bioinspired Nanoplatelets for Chemo-Photothermal Therapy of Breast Cancer Metastasis Inhibition. Biomaterials 2019, 206, 1–12..
Not in our library10.1016/j.biomaterials.2019.03.024
88.
Zhao H.; Li L.; Zhang J.; Zheng C.; Ding K.; Xiao H.; Wang L.; Zhang Z. CCL2 Recruits Macrophage-Membrane-Camouflaged Hollow Bismuth Selenide Nanoparticles To Facilitate Photothermal Sensitivity and Inhibit Lung Metastasis of Breast Cancer. ACS Appl. Mater. Interfaces 2018, 10, 31124–31135..
Not in our library10.1021/acsami.8b11645
89.
Zou S.; Wang B.; Wang C.; Wang C.; Zhang L. Cell Membrane-Coated Nanoparticles: Research Advances. Nanomedicine 2020, 15, 625–641..
Not in our library10.2217/nnm-2019-0388
90.
Lejeune A.; Moorjani M.; Gicquaud C.; Lacroix J.; Poyet P.; Gaudreault R. Nanoerythrosome, a New Derivative of Erythrocyte Ghost: Preparation and Antineoplastic Potential As Drug Carrier for Daunorubicin. Anticancer Res. 1994, 14, 915–920.
Not in our library
91.
Gong H.; Zhang Q.; Komarla A.; Wang S.; Duan Y.; Zhou Z.; Chen F.; Fang R. H.; Xu S.; Gao W.; Zhang L. Nanomaterial Biointerfacing via Mitochondrial Membrane Coating for Targeted Detoxification and Molecular Detection. Nano Lett. 2021, 21, 2603–2609..
Not in our library10.1021/acs.nanolett.1c00238
92.
Fang R. H.; Hu C. M.; Luk B. T.; Gao W.; Copp J. A.; Tai Y.; O’Connor D. E.; Zhang L. Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery. Nano Lett. 2014, 14, 2181–2188..
Not in our library10.1021/nl500618u
93.
Hu C. M.; Fang R. H.; Wang K. C.; Luk B. T.; Thamphiwatana S.; Dehaini D.; Nguyen P.; Angsantikul P.; Wen C. H.; Kroll A. V.; Carpenter C.; Ramesh M.; Qu V.; Patel S. H.; Zhu J.; Shi W.; Hofman F. M.; Chen T. C.; Gao W.; Zhang K.; Chien S.; Zhang L. Nanoparticle Biointerfacing by Platelet Membrane Cloaking. Nature 2015, 526, 118–121..
Not in our library10.1038/nature15373
94.
Gao W.; Fang R. H.; Thamphiwatana S.; Luk B. T.; Li J.; Angsantikul P.; Zhang Q.; Hu C. M.; Zhang L. Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles. Nano Lett. 2015, 15, 1403–1409..
Not in our library10.1021/nl504798g
95.
Lai P.-Y.; Huang R.-Y.; Lin S.-Y.; Lin Y.-H.; Chang C.-W. Biomimetic Stem Cell Membrane-Camouflaged Iron Oxide Nanoparticles for Theranostic Applications. RSC Adv. 2015, 5, 98222–98230..
Not in our library10.1039/c5ra17447c
96.
Chen W.; Zhang Q.; Luk B. T.; Fang R. H.; Liu Y.; Gao W.; Zhang L. Coating Nanofiber Scaffolds with Beta Cell Membrane to Promote Cell Proliferation and Function. Nanoscale 2016, 8, 10364–10370..
Not in our library10.1039/c6nr00535g
97.
Dehaini D.; Wei X.; Fang R. H.; Masson S.; Angsantikul P.; Luk B. T.; Zhang Y.; Ying M.; Jiang Y.; Kroll A. V.; Gao W.; Zhang L. Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization. Adv. Mater. 2017, 29, 1606209–1606216..
Not in our library10.1002/adma.201606209
98.
Zhang L.; Li R.; Chen H.; Wei J.; Qian H.; Su S.; Shao J.; Wang L.; Qian X.; Liu B. Human Cytotoxic T-Lymphocyte Membrane-Camouflaged Nanoparticles Combined with Low-Dose Irradiation: A New Approach to Enhance Drug Targeting in Gastric Cancer. Int. J. Nanomed. 2017, 12, 2129–2142..
Not in our library10.2147/ijn.s126016
99.
Rao L.; Meng Q.-F.; Huang Q.; Wang Z.; Yu G.-T.; Li A.; Ma W.; Zhang N.; Guo S.-S.; Zhao X.-Z.; Liu K.; Yuan Y.; Liu W. Platelet-Leukocyte Hybrid Membrane-Coated Immunomagnetic Beads for Highly Efficient and Highly Specific Isolation of Circulating Tumor Cells. Adv. Funct. Mater. 2018, 28, 1803531–1803539..
Not in our library10.1002/adfm.201803531
100.
Wang D.; Dong H.; Li M.; Cao Y.; Yang F.; Zhang K.; Dai W.; Wang C.; Zhang X. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma. ACS Nano 2018, 12, 5241–5252..
Not in our library10.1021/acsnano.7b08355
101.
Angsantikul P.; Thamphiwatana S.; Zhang Q.; Spiekermann K.; Zhuang J.; Fang R. H.; Gao W.; Obonyo M.; Zhang L. Coating Nanoparticles with Gastric Epithelial Cell Membrane for Targeted Antibiotic Delivery against Helicobacter Pylori Infection. Adv. Therap. 2018, 1, 1800016–1800024..
Not in our library10.1002/adtp.201800016
102.
Pitchaimani A.; Nguyen T. D. T.; Aryal S. Natural Killer Cell Membrane Infused Biomimetic Liposomes for Targeted Tumor Therapy. Biomaterials 2018, 160, 124–137..
Not in our library10.1016/j.biomaterials.2018.01.018
103.
Huang Y.; Mei C.; Tian Y.; Nie T.; Liu Z.; Chen T. Bioinspired Tumor-Homing Nanosystem for Precise Cancer Therapy via Reprogramming of Tumor-Associated Macrophages. NPG Asia Mater. 2018, 10, 1002–1015..
Not in our library10.1038/s41427-018-0091-9
104.
Li J.; Zhen X.; Lyu Y.; Jiang Y.; Huang J.; Pu K. Cell Membrane Coated Semiconducting Polymer Nanoparticles for Enhanced Multimodal Cancer Phototheranostics. ACS Nano 2018, 12, 8520–8530..
Not in our library10.1021/acsnano.8b04066
105.
Rao L.; Yu G. T.; Meng Q. F.; Bu L. L.; Tian R.; Lin L. S.; Deng H.; Yang W.; Zan M.; Ding J.; Li A.; Xiao H.; Sun Z. J.; Liu W.; Chen X. Cancer Cell Membrane-Coated Nanoparticles for Personalized Therapy in Patient-Derived Xenograft Models. Adv. Funct. Mater. 2019, 29, 1905671–1905680..
Not in our library10.1002/adfm.201905671
106.
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer · 2020
No notice
107.
Bosman G. J. Survival of Red Blood Cells After Transfusion: Processes and Consequences. Front. Physiol. 2013, 4, 376–383..
Not in our library10.3389/fphys.2013.00376
108.
Xia Q.; Zhang Y.; Li Z.; Hou X.; Feng N. Red Blood Cell Membrane-Camouflaged Nanoparticles: A Novel Drug Delivery System for Antitumor Application. Acta Pharm. Sin. B 2019, 9, 675–689..
Not in our library10.1016/j.apsb.2019.01.011
109.
Villa C. H.; Anselmo A. C.; Mitragotri S.; Muzykantov V. Red Blood Cells: Supercarriers for Drugs, Biologicals, and Nanoparticles and Inspiration for Advanced Delivery Systems. Adv. Drug Delivery Rev. 2016, 106, 88–103..
Not in our library10.1016/j.addr.2016.02.007
110.
CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy · 2020
No notice
111.
Benedik P. S.; Hamlin S. K. The Physiologic Role of Erythrocytes in Oxygen Delivery and Implications for Blood Storage. Crit. Care Nurs. Clin. North Am. 2014, 26, 325–335..
Not in our library10.1016/j.ccell.2014.04.002
112.
Minasyan H. Phagocytosis and Oxycytosis: Two Arms of Human Innate Immunity. Immunol. Res. 2018, 66, 271–280..
Not in our library10.1007/s12026-018-8988-5
113.
Red Blood Cells: Chasing Interactions · 2019
No notice
114.
Zhang Y.; Zhang J.; Chen W.; Angsantikul P.; Spiekermann K. A.; Fang R. H.; Gao W.; Zhang L. Erythrocyte Membrane-Coated Nanogel for Combinatorial Antivirulence and Responsive Antimicrobial Delivery against Staphylococcus Aureus Infection. J. Controlled Release 2017, 263, 185–191..
Not in our library10.1016/j.jconrel.2017.01.016
115.
Hu C. M.; Fang R. H.; Copp J.; Luk B. T.; Zhang L. A Biomimetic Nanosponge That Absorbs Pore-Forming Toxins. Nat. Nanotechnol. 2013, 8, 336–340..
Not in our library10.1038/nnano.2013.54
116.
Hou Y.; Carrim N.; Wang Y.; Gallant R. C.; Marshall A.; Ni H. Platelets in Hemostasis and Thrombosis: Novel Mechanisms of Fibrinogen-Independent Platelet Aggregation and Fibronectin-Mediated Protein Wave of Hemostasis. J. Biomed. Res. 2015, 29, 437–444..
Not in our library10.7555/jbr.29.20150121
117.
Lavergne M.; Janus-Bell E.; Schaff M.; Gachet C.; Mangin P. H. Platelet Integrins in Tumor Metastasis: Do they Represent a Therapeutic Target?. Cancers 2017, 9, 133–149..
Not in our library10.3390/cancers9100133
118.
Andrews R. K.; López J.; Berndt M. C. Molecular Mechanisms of Platelet Adhesion and Activation. Int. J. Biochem. Cell Biol. 1997, 29, 91–105..
Not in our library10.1016/s1357-2725(96)00122-7
119.
Portier I.; Campbell R. A. Role of Platelets in Detection and Regulation of Infection. Arterioscler., Thromb., Vasc. Biol. 2020, 41, 70–78..
Not in our library10.1161/atvbaha.120.314645
120.
Andrews R. K.; Lopez J. A.; Berndt M. C. Molecular Mechanisms of Platelet Adhesion and Activation. Int. J. Biochem. Cell Biol. 1997, 29, 91–105..
Not in our library10.1016/s1357-2725(96)00122-7
121.
Xu L.; Gao F.; Fan F.; Yang L. Platelet Membrane Coating Coupled with Solar Irradiation Endows a Photodynamic Nanosystem with Both Improved Antitumor Efficacy and Undetectable Skin Damage. Biomaterials 2018, 159, 59–67..
Not in our library10.1016/j.biomaterials.2017.12.028
122.
Wang B.; Chen G.; Urabe G.; Xie R.; Wang Y.; Shi X.; Guo L. W.; Gong S.; Kent K. C. A Paradigm of Endothelium-Protective and Stent-Free Anti-Restenotic Therapy Using Biomimetic Nanoclusters. Biomaterials 2018, 178, 293–301..
Not in our library10.1016/j.biomaterials.2018.06.025
123.
Wei X.; Ying M.; Dehaini D.; Su Y.; Kroll A. V.; Zhou J.; Gao W.; Fang R. H.; Chien S.; Zhang L. Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis. ACS Nano 2018, 12, 109–116..
Not in our library10.1021/acsnano.7b07720
124.
The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis · 2017
No notice
125.
Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials · 2015
No notice
126.
Shi C.; Pamer E. G. Monocyte Recruitment during Infection and Inflammation. Nat. Rev. Immunol. 2011, 11, 762–574..
Not in our library10.1038/nri3070
127.
Taylor P. R.; Martinez-Pomares L.; Stacey M.; Lin H. H.; Brown G. D.; Gordon S. Macrophage Receptors and Immune Recognition. Annu. Rev. Immunol. 2005, 23, 901–944..
Not in our library10.1146/annurev.immunol.23.021704.115816
128.
Si J.; Shao S.; Shen Y.; Wang K. Macrophages As Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy. Small 2016, 12, 5108–5119..
Not in our library10.1002/smll.201601282
129.
Cao H.; Dan Z.; He X.; Zhang Z.; Yu H.; Yin Q.; Li Y. Liposomes Coated with Isolated Macrophage Membrane can Target Lung Metastasis of Breast Cancer. ACS Nano 2016, 10, 7738–7748..
Not in our library10.1021/acsnano.6b03148
130.
Thamphiwatana S.; Angsantikul P.; Escajadillo T.; Zhang Q.; Olson J.; Luk B. T.; Zhang S.; Fang R. H.; Gao W.; Nizet V.; Zhang L. Macrophage-Like Nanoparticles Concurrently Absorbing Endotoxins and Proinflammatory Cytokines for Sepsis Management. Proc. Natl. Acad. Sci. U. S. A. 2017, 114, 11488–11493..
Not in our library10.1073/pnas.1714267114
131.
Meng Q. F.; Rao L.; Zan M.; Chen M.; Yu G. T.; Wei X.; Wu Z.; Sun Y.; Guo S. S.; Zhao X. Z.; Wang F. B.; Liu W. Macrophage Membrane-Coated Iron Oxide Nanoparticles for Enhanced Photothermal Tumor Therapy. Nanotechnology 2018, 29, 134004.
Not in our library10.1088/1361-6528/aaa7c7
132.
Rao L.; He Z.; Meng Q. F.; Zhou Z.; Bu L. L.; Guo S. S.; Liu W.; Zhao X. Z. Effective Cancer Targeting and Imaging Using Macrophage Membrane-Camouflaged Upconversion Nanoparticles. J. Biomed. Mater. Res., Part A 2017, 105, 521–530..
Not in our library10.1002/jbm.a.35927
133.
Wright H. L.; Moots R. J.; Bucknall R. C.; Edwards S. W. Neutrophil Function in Inflammation and Inflammatory Diseases. Rheumatology 2010, 49, 1618–1631..
Not in our library10.1093/rheumatology/keq045
134.
An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration · 2017
No notice
135.
Update on Neutrophil Function in Severe Inflammation · 2018
No notice
136.
de Oliveira S.; Rosowski E. E.; Huttenlocher A. Neutrophil Migration in Infection and Wound Repair: Going Forward in Reverse. Nat. Rev. Immunol. 2016, 16, 378–391..
Not in our library10.1038/nri.2016.49
137.
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? · 2018
No notice
138.
Morikis V. A.; Simon S. I. Neutrophil Mechanosignaling Promotes Integrin Engagement with Endothelial Cells and Motility within Inflamed Vessels. Front. Immunol. 2018, 9, 2774–2787..
Not in our library10.3389/fimmu.2018.02774
139.
Xuan M.; Shao J.; Dai L.; Li J.; He Q. Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy. ACS Appl. Mater. Interfaces 2016, 8, 9610–9618..
Not in our library10.1021/acsami.6b00853
140.
Natural Killer Cells: Development, Maturation, and Clinical Utilization · 2018
No notice
141.
Natural killer cells in cancer biology and therapy · 2020
No notice
142.
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy · 2015
No notice
143.
Lorenzo-Herrero S.; Lopez-Soto A.; Sordo-Bahamonde C.; Gonzalez-Rodriguez A. P.; Vitale M.; Gonzalez S. NK Cell-Based Immunotherapy in Cancer Metastasis. Cancers 2019, 11, 29.
Not in our library10.3390/cancers11010029
144.
Vivier E.; Ugolini S.; Blaise D.; Chabannon C.; Brossay L. Targeting Natural Killer Cells and Natural Killer T Cells in Cancer. Nat. Rev. Immunol. 2012, 12, 239–252..
Not in our library10.1038/nri3174
145.
Cheng M.; Zhang J.; Jiang W.; Chen Y.; Tian Z. Natural Killer Cell lines in Tumor Immunotherapy. Front. Med. 2012, 6, 56–66..
Not in our library10.1007/s11684-012-0177-7
146.
Suck G.; Branch D. R.; Smyth M. J.; Miller R. G.; Vergidis J.; Fahim S.; Keating A. KHYG-1, A Model for the Study of Enhanced Natural Killer Cell Cytotoxicity. Exp. Hematol. 2005, 33, 1160–1171..
Not in our library10.1016/j.exphem.2005.06.024
147.
Zhang J.; Zheng H.; Diao Y. Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy. Int. J. Mol. Sci. 2019, 20, 317–336..
Not in our library10.3390/ijms20020317
148.
Murakami T.; Nakazawa T.; Natsume A.; Nishimura F.; Nakamura M.; Matsuda R.; Omoto K.; Tanaka Y.; Shida Y.; Park Y. S.; Motoyama Y.; Nakagawa I.; Yamada S.; Tamura K.; Takeshima Y.; Takamura Y.; Wakabayashi T.; Nakase H. Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells. Anticancer Res. 2018, 38, 5049–5056..
Not in our library10.21873/anticanres.12824
149.
Xie G.; Dong H.; Liang Y.; Ham J. D.; Rizwan R.; Chen J. CAR-NK Cells: A Promising Cellular Immunotherapy for Cancer. EBioMedicine 2020, 59, 102975–102984..
Not in our library10.1016/j.ebiom.2020.102975
150.
Deng G.; Sun Z.; Li S.; Peng X.; Li W.; Zhou L.; Ma Y.; Gong P.; Cai L. Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth. ACS Nano 2018, 12, 12096–12108..
Not in our library10.1021/acsnano.8b05292
151.
Kumar B. V.; Connors T. J.; Farber D. L. Human T Cell Development, Localization, and Function throughout Life. Immunity 2018, 48, 202–213..
Not in our library10.1016/j.immuni.2018.01.007
152.
Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis · 2019
No notice
153.
Uzhachenko R. V.; Shanker A. CD8(+) T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity. Front. Immunol. 2019, 10, 1906–1912..
Not in our library10.3389/fimmu.2019.01906
154.
Swain S. L.; McKinstry K. K.; Strutt T. M. Expanding Roles for CD4(+) T Cells in Immunity to Viruses. Nat. Rev. Immunol. 2012, 12, 136–148..
Not in our library10.1038/nri3152
155.
Okoye A. A.; Picker L. J. CD4(+) T-cell Depletion in HIV Infection: Mechanisms of Immunological Failure. Immunol. Rev. 2013, 254, 54–64..
Not in our library10.1111/imr.12066
156.
CAR-T cell therapy: current limitations and potential strategies · 2021
No notice
157.
Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment · 2020
No notice
158.
T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy · 2019
No notice
159.
Wei X.; Zhang G.; Ran D.; Krishnan N.; Fang R. H.; Gao W.; Spector S. A.; Zhang L. T-Cell-Mimicking Nanoparticles can Neutralize HIV Infectivity. Adv. Mater. 2018, 30, 1802233–1802241..
Not in our library10.1002/adma.201802233
160.
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy · 2019
No notice
161.
Dendritic cell biology and its role in tumor immunotherapy · 2020
No notice
162.
Geginat J.; Nizzoli G.; Paroni M.; Maglie S.; Larghi P.; Pascolo S.; Abrignani S. Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets. Front. Immunol. 2015, 6, 527–539..
Not in our library10.3389/fimmu.2015.00527
163.
Platt C. D.; Ma J. K.; Chalouni C.; Ebersold M.; Bou-Reslan H.; Carano R. A.; Mellman I.; Delamarre L. Mature Dendritic Cells Use Endocytic Receptors to Capture and Present Antigens. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 4287–4292..
Not in our library10.1073/pnas.0910609107
164.
Mbongue J. C.; Nieves H. A.; Torrez T. W.; Langridge W. H. The Role of Dendritic Cell Maturation in the Induction of Insulin-Dependent Diabetes Mellitus. Front. Immunol. 2017, 8, 327–335..
Not in our library10.3389/fimmu.2017.00327
165.
Kaiko G. E.; Horvat J. C.; Beagley K. W.; Hansbro P. M. Immunological Decision-Making: How Does the Immune System Decide to Mount a Helper T-Cell Response?. Immunology 2008, 123, 326–338..
Not in our library10.1111/j.1365-2567.2007.02719.x
166.
Anne Gowda V. M.; Smitha T. The Dendritic Cell Tool for Oral Cancer Treatment. J. Oral Maxillofac. Pathol. 2019, 23, 326–329..
Not in our library10.4103/jomfp.jomfp_325_19
167.
Martin-Gayo E.; Yu X. G. Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection. Front. Immunol. 2019, 10, 1306–1314..
Not in our library10.3389/fimmu.2019.01306
168.
Liu W. L.; Zou M. Z.; Liu T.; Zeng J. Y.; Li X.; Yu W. Y.; Li C. X.; Ye J. J.; Song W.; Feng J.; Zhang X. Z. Expandable Immunotherapeutic Nanoplatforms Engineered from Cytomembranes of Hybrid Cells Derived from Cancer and Dendritic Cells. Adv. Mater. 2019, 31, 1900499–1900508..
Not in our library10.1002/adma.201900499
169.
Nath S.; Mukherjee P. MUC1: A Multifaceted Oncoprotein with a Key Role in Cancer Progression. Trends Mol. Med. 2014, 20, 332–342..
Not in our library10.1016/j.molmed.2014.02.007
170.
The functional role of integrins during intra- and extravasation within the metastatic cascade · 2019
No notice
171.
Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration · 2017
No notice
172.
Bose R. J.; Paulmurugan R.; Moon J.; Lee S. H.; Park H. Cell Membrane-Coated Nanocarriers: The Emerging Targeted Delivery System for Cancer Theranostics. Drug Discovery Today 2018, 23, 891–899..
Not in our library10.1016/j.drudis.2018.02.001
173.
Zhu J.; Zhang M.; Zheng D.; Hong S.; Feng J.; Zhang X. Z. A Universal Approach to Render Nanomedicine with Biological Identity Derived from Cell Membranes. Biomacromolecules 2018, 19, 2043–2052..
Not in our library10.1021/acs.biomac.8b00242
174.
Zhang J.; Miao Y.; Ni W.; Xiao H.; Zhang J. Cancer Cell Membrane-Coated Silica Nanoparticles Loaded with ICG for Tumour Specific Photothermal Therapy of Osteosarcoma. Artif. Cells, Nanomed., Biotechnol. 2019, 47, 2298–2305..
Not in our library10.1080/21691401.2019.1622554
175.
Nie D.; Dai Z.; Li J.; Yang Y.; Xi Z.; Wang J.; Zhang W.; Qian K.; Guo S.; Zhu C.; Wang R.; Li Y.; Yu M.; Zhang X.; Shi X.; Gan Y. Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk–Shell Structure Augment Cancer Chemotherapy. Nano Lett. 2020, 20, 936–946..
Not in our library10.1021/acs.nanolett.9b03817
176.
Mesenchymal Stem Cells for Regenerative Medicine · 2019
No notice
177.
Rodriguez-Fuentes D. E.; Fernandez-Garza L. E.; Samia-Meza J. A.; Barrera-Barrera S. A.; Caplan A. I.; Barrera-Saldana H. A. Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review. Arch. Med. Res. 2021, 52, 93–101..
Not in our library10.1016/j.arcmed.2020.08.006
178.
Kabat M.; Bobkov I.; Kumar S.; Grumet M. Trends in Mesenchymal Stem Cell Clinical Trials 2004–2018: Is Efficacy Optimal in a Narrow Dose Range?. Stem Cells Transl. Med. 2020, 9, 17–27..
Not in our library10.1002/sctm.19-0202
179.
Stuckey D. W.; Shah K. Stem Cell-Based Therapies for Cancer treatment: Separating Hope from Hype. Nat. Rev. Cancer 2014, 14, 683–691..
Not in our library10.1038/nrc3798
180.
Wu H. H.; Zhou Y.; Tabata Y.; Gao J. Q. Mesenchymal Stem Cell-Based Drug Delivery Strategy: From Cells to Biomimetic. J. Controlled Release 2019, 294, 102–113..
Not in our library10.1016/j.jconrel.2018.12.019
181.
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy · 2020
No notice
182.
Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application · 2016
Not checked
183.
Vitillo L.; Durance C.; Hewitt Z.; Moore H.; Smith A.; Vallier L. GMP-Grade Neural Progenitor Derivation and Differentiation from Clinical-Grade Human Embryonic Stem Cells. Stem Cell Res. Ther. 2020, 11, 406–415..
Not in our library10.1186/s13287-020-01915-0
184.
Heirani-Tabasi A.; Toosi S.; Mirahmadi M.; Mishan M. A.; Bidkhori H. R.; Bahrami A. R.; Behravan J.; Naderi-Meshkin H. Chemokine Receptors Expression in MSCs: Comparative Analysis in Different Sources and Passages. Tissue Eng. Regener. Med. 2017, 14, 605–615..
Not in our library10.1007/s13770-017-0069-7
185.
Gao C.; Lin Z.; Wu Z.; Lin X.; He Q. Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy. ACS Appl. Mater. Interfaces 2016, 8, 34252–34260..
Not in our library10.1021/acsami.6b12865
186.
Gao C.; Lin Z.; Jurado-Sanchez B.; Lin X.; Wu Z.; He Q. Stem Cell Membrane-Coated Nanogels for Highly Efficient in Vivo Tumor Targeted Drug Delivery. Small 2016, 12, 4056–4062..
Not in our library10.1002/smll.201600624
187.
Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome · 2017
No notice
188.
Ma J.; Zhang S.; Liu J.; Liu F.; Du F.; Li M.; Chen A. T.; Bao Y.; Suh H. W.; Avery J.; Deng G.; Zhou Y.; Wu P.; Sheth K.; Wang H.; Zhou J. Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells. Small 2019, 15, 1902011–1902018..
Not in our library10.1002/smll.201902011
189.
Silhavy T. J.; Kahne D.; Walker S. The Bacterial Cell Envelope. Cold Spring Harbor Perspect. Biol. 2010, 2, a000414.
Not in our library10.1101/cshperspect.a000414
190.
Lee E. Y.; Choi D. Y.; Kim D. K.; Kim J. W.; Park J. O.; Kim S.; Kim S. H.; Desiderio D. M.; Kim Y. K.; Kim K. P.; Gho Y. S. Gram-Positive Bacteria Produce Membrane Vesicles: Proteomics-Based Characterization of Staphylococcus Aureus-Derived Membrane Vesicles. Proteomics 2009, 9, 5425–5436..
Not in our library10.1002/pmic.200900338
191.
Kaparakis-Liaskos M.; Ferrero R. L. Immune Modulation by Bacterial Outer Membrane Vesicles. Nat. Rev. Immunol. 2015, 15, 375–387..
Not in our library10.1038/nri3837
192.
Gao F.; Xu L.; Yang B.; Fan F.; Yang L. Kill the Real with the Fake: Eliminate Intracellular Staphylococcus Aureus Using Nanoparticle Coated with its Extracellular Vesicle Membrane As Active-Targeting Drug Carrier. ACS Infect. Dis. 2019, 5, 218–227..
Not in our library10.1021/acsinfecdis.8b00212
193.
Wu G.; Ji H.; Guo X.; Li Y.; Ren T.; Dong H.; Liu J.; Liu Y.; Shi X.; He B. Nanoparticle Reinforced Bacterial Outer-Membrane Vesicles Effectively Prevent Fatal Infection of Carbapenem-Resistant Klebsiella Pneumonia. Nanomedicine 2020, 24, 102148–102158..
Not in our library10.1016/j.nano.2019.102148
194.
Bioengineered bacterial vesicles as biological nano-heaters for optoacoustic imaging · 2019
No notice
195.
Gujrati V.; Kim S.; Kim S. H.; Min J. J.; Choy H. E.; Kim S. C.; Jon S. Bioengineered Bacterial Outer Membrane Vesicles As Cell-Specific Drug-Delivery Vehicles for Cancer Therapy. ACS Nano 2014, 8, 1525–1537..
Not in our library10.1021/nn405724x
196.
Esteban-Fernandez de Avila B.; Angsantikul P.; Ramirez-Herrera D. E.; Soto F.; Teymourian H.; Dehaini D.; Chen Y.; Zhang L.; Wang J. Hybrid Biomembrane-Functionalized Nanorobots for Concurrent Removal of Pathogenic Bacteria and Toxins. Sci. Rob. 2018, 3, eaat0485.
Not in our library10.1126/scirobotics.aat0485
197.
Chen H. Y.; Deng J.; Wang Y.; Wu C. Q.; Li X.; Dai H. W. Hybrid Cell Membrane-Coated Nanoparticles: A Multifunctional Biomimetic Platform for Cancer Diagnosis and Therapy. Acta Biomater. 2020, 112, 1–13..
Not in our library10.1016/j.actbio.2020.05.028
198.
Jiang Q.; Liu Y.; Guo R.; Yao X.; Sung S.; Pang Z.; Yang W. Erythrocyte-Cancer Hybrid Membrane-Camouflaged Melanin Nanoparticles for Enhancing Photothermal Therapy Efficacy in Tumors. Biomaterials 2019, 192, 292–308..
Not in our library10.1016/j.biomaterials.2018.11.021
199.
Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy · 2020
No notice
200.
Wang D.; Liu C.; You S.; Zhang K.; Li M.; Cao Y.; Wang C.; Dong H.; Zhang X. Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy. ACS Appl. Mater. Interfaces 2020, 12, 41138–41147..
Not in our library10.1021/acsami.0c13169
201.
Chen M. S.; Zhang Y.; Zhang L. Fabrication and Characterization of a 3D Bioprinted Nanoparticle-Hydrogel Hybrid Device for Biomimetic Detoxification. Nanoscale 2017, 9, 14506–14511..
Not in our library10.1039/c7nr05322c
202.
Klymchenko A. S.; Kreder R. Fluorescent Probes for Lipid Rafts: From Model Membranes to Living Cells. Chem. Biol. 2014, 21, 97–113..
Not in our library10.1016/j.chembiol.2013.11.009
203.
Yao J.; Fan Y.; Li Y.; Huang L. Strategies on the Nuclear-Targeted Delivery of Genes. J. Drug Target 2013, 21, 926–939..
Not in our library10.3109/1061186x.2013.830310
204.
Grandinetti G.; Smith A. E.; Reineke T. M. Membrane and Nuclear Permeabilization by Polymeric pDNA Vehicles: Efficient Method for Gene Delivery or Mechanism of Cytotoxicity?. Mol. Pharmaceutics 2012, 9, 523–538..
Not in our library10.1021/mp200368p
205.
Miller S.; Krijnse-Locker J. Modification of Intracellular Membrane Structures for Virus Replication. Nat. Rev. Microbiol. 2008, 6, 363–374..
Not in our library10.1038/nrmicro1890
206.
Nurunnabi M.; Khatun Z.; Badruddoza A. Z. M.; McCarthy J. R.; Lee Y.-k.; Huh K. M. Biomaterials and Bioengineering Approaches for Mitochondria and Nuclear Targeting Drug Delivery. ACS Biomater. Sci. Eng. 2019, 5, 1645–1660..
Not in our library10.1021/acsbiomaterials.8b01615
207.
Rao L.; Bu L.-L.; Meng Q.-F.; Cai B.; Deng W.-W.; Li A.; Li K.; Guo S.-S.; Zhang W.-F.; Liu W.; Sun Z.-J.; Zhao X.-Z. Antitumor Platelet-Mimicking Magnetic Nanoparticles. Adv. Funct. Mater. 2017, 27, 1604774–1604783..
Not in our library10.1002/adfm.201604774
208.
Suski J. M.; Lebiedzinska M.; Wojtala A.; Duszynski J.; Giorgi C.; Pinton P.; Wieckowski M. R. Isolation of Plasma Membrane-Associated Membranes from Rat Liver. Nat. Protoc. 2014, 9, 312–322..
Not in our library10.1038/nprot.2014.016
209.
Zhang N.; Li M.; Sun X.; Jia H.; Liu W. NIR-Responsive Cancer Cytomembrane-Cloaked Carrier-Free Nanosystems for Highly Efficient and Self-Targeted Tumor Drug Delivery. Biomaterials 2018, 159, 25–36..
Not in our library10.1016/j.biomaterials.2018.01.007
210.
Han X.; Shen S.; Fan Q.; Chen G.; Archibong E.; Dotti G.; Liu Z.; Gu Z.; Wang C. Red Blood Cell-Derived Nanoerythrosome for Antigen Delivery with Enhanced Cancer Immunotherapy. Sci. Adv. 2019, 5, eaaw6870.
Not in our library10.1126/sciadv.aaw6870
211.
Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management · 2019
No notice
212.
Wei X.; Gao J.; Fang R. H.; Luk B. T.; Kroll A. V.; Dehaini D.; Zhou J.; Kim H. W.; Gao W.; Lu W.; Zhang L. Nanoparticles Camouflaged in Platelet Membrane Coating As an Antibody Decoy for the Treatment of Immune Thrombocytopenia. Biomaterials 2016, 111, 116–123..
Not in our library10.1016/j.biomaterials.2016.10.003
213.
Li J.; Ai Y.; Wang L.; Bu P.; Sharkey C. C.; Wu Q.; Wun B.; Roy S.; Shen X.; King M. R. Targeted Drug Delivery to Circulating Tumor Cells via Platelet Membrane-Functionalized Particles. Biomaterials 2016, 76, 52–65..
Not in our library10.1016/j.biomaterials.2015.10.046
214.
Fusciello M.; Fontana F.; Tahtinen S.; Capasso C.; Feola S.; Martins B.; Chiaro J.; Peltonen K.; Ylosmaki L.; Ylosmaki E.; Hamdan F.; Kari O. K.; Ndika J.; Alenius H.; Urtti A.; Hirvonen J. T.; Santos H. A.; Cerullo V. Artificially Cloaked Viral Nanovaccine for Cancer Immunotherapy. Nat. Commun. 2019, 10, 5747–5759..
Not in our library10.1038/s41467-019-13744-8
215.
Grouleff J.; Irudayam S. J.; Skeby K. K.; Schiott B. The Influence of Cholesterol on Membrane Protein Structure, Function, and Dynamics Studied by Molecular Dynamics Simulations. Biochim. Biophys. Acta, Biomembr. 2015, 1848, 1783–1795..
Not in our library10.1016/j.bbamem.2015.03.029
216.
Chakraborty S.; Doktorova M.; Molugu T. R.; Heberle F. A.; Scott H. L.; Dzikovski B.; Nagao M.; Stingaciu L. R.; Standaert R. F.; Barrera F. N.; Katsaras J.; Khelashvili G.; Brown M. F.; Ashkar R. How Cholesterol Stiffens Unsaturated Lipid Membranes. Proc. Natl. Acad. Sci. U. S. A. 2020, 117, 21896–21905..
Not in our library10.1073/pnas.2004807117
217.
An X.; Salomao M.; Guo X.; Gratzer W.; Mohandas N. Tropomyosin Modulates Erythrocyte Membrane Stability. Blood 2007, 109, 1284–1288..
Not in our library10.1182/blood-2006-07-036954
218.
Wong P. A Basis of the Crenation of Erythrocyte Ghosts by Electrolytes. Open Biol. J. 2013, 6, 14–19..
Not in our library10.2174/1874196701306010014
219.
Wang J.; Wang Z.; Zhong Y.; Zou Y.; Wang C.; Wu H.; Lee A.; Yang W.; Wang X.; Liu Y.; Zhang D.; Yan J.; Hao M.; Zheng M.; Chung R.; Bai F.; Shi B. Central Metal-Derived Co-Assembly of Biomimetic Gdtpp/Zntpp Porphyrin Nanocomposites for Enhanced Dual-Modal Imaging-Guided Photodynamic Therapy. Biomaterials 2020, 229, 119576–119588..
Not in our library10.1016/j.biomaterials.2019.119576
220.
Sun H.; Su J.; Meng Q.; Yin Q.; Chen L.; Gu W.; Zhang P.; Zhang Z.; Yu H.; Wang S.; Li Y. Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors. Adv. Mater. 2016, 28, 9581–9588..
Not in our library10.1002/adma.201602173
221.
Sun H.; Su J.; Meng Q.; Yin Q.; Chen L.; Gu W.; Zhang Z.; Yu H.; Zhang P.; Wang S.; Li Y. Cancer Cell Membrane-Coated Gold Nanocages with Hyperthermia-Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer. Adv. Funct. Mater. 2017, 27, 1604300–1604308..
Not in our library10.1002/adfm.201604300
222.
Kroll A. V.; Fang R. H.; Jiang Y.; Zhou J.; Wei X.; Yu C. L.; Gao J.; Luk B. T.; Dehaini D.; Gao W.; Zhang L. Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity. Adv. Mater. 2017, 29, 1703969–1703977..
Not in our library10.1002/adma.201703969
223.
Rao L.; Bu L.-L.; Cai B.; Xu J.-H.; Li A.; Zhang W.-F.; Sun Z.-J.; Guo S.-S.; Liu W.; Wang T.-H.; Zhao X.-Z. Cancer Cell Membrane-Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging. Adv. Mater. 2016, 28, 3460–3466..
Not in our library10.1002/adma.201506086
224.
Jin J.; Krishnamachary B.; Barnett J. D.; Chatterjee S.; Chang D.; Mironchik Y.; Wildes F.; Jaffee E. M.; Nimmagadda S.; Bhujwalla Z. M. Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells. ACS Appl. Mater. Interfaces 2019, 11, 7850–7861..
Not in our library10.1021/acsami.8b22309
225.
Liu C. M.; Chen G. B.; Chen H. H.; Zhang J. B.; Li H. Z.; Sheng M. X.; Weng W. B.; Guo S. M. Cancer Cell Membrane-Cloaked Mesoporous Silica Nanoparticles with a pH-Sensitive Gatekeeper for Cancer Treatment. Colloids Surf., B 2019, 175, 477–486..
Not in our library10.1016/j.colsurfb.2018.12.038
226.
Xu Q.; Wan J.; Bie N.; Song X.; Yang X.; Yong T.; Zhao Y.; Yang X.; Gan L. A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation. Theranostics 2018, 8, 5362–5378..
Not in our library10.7150/thno.27631
227.
Bose R. J.; Kim B. J.; Arai Y.; Han I. B.; Moon J. J.; Paulmurugan R.; Park H.; Lee S. H. Bioengineered Stem Cell Membrane Functionalized Nanocarriers for Therapeutic Targeting of Severe Hindlimb Ischemia. Biomaterials 2018, 185, 360–370..
Not in our library10.1016/j.biomaterials.2018.08.018
228.
Rao L.; Wang W.; Meng Q. F.; Tian M.; Cai B.; Wang Y.; Li A.; Zan M.; Xiao F.; Bu L. L.; Li G.; Li A.; Liu Y.; Guo S. S.; Zhao X. Z.; Wang T. H.; Liu W.; Wu J. A Biomimetic Nanodecoy Traps Zika Virus to Prevent Viral Infection and Fetal Microcephaly Development. Nano Lett. 2019, 19, 2215–2222..
Not in our library10.1021/acs.nanolett.8b03913
229.
Virlan M. J.; Miricescu D.; Radulescu R.; Sabliov C. M.; Totan A.; Calenic B.; Greabu M. Organic Nanomaterials and Their Applications in the Treatment of Oral Diseases. Molecules 2016, 21, 207–229..
Not in our library10.3390/molecules21020207
230.
Anselmo A. C.; Mitragotri S. A Review of Clinical Translation of Inorganic Nanoparticles. AAPS J. 2015, 17, 1041–1054..
Not in our library10.1208/s12248-015-9780-2
231.
Biodegradable and Renal Clearable Inorganic Nanoparticles · 2015
No notice
232.
Wang A. Z.; Langer R.; Farokhzad O. C. Nanoparticle Delivery of Cancer Drugs. Annu. Rev. Med. 2012, 63, 185–198..
Not in our library10.1146/annurev-med-040210-162544
233.
Systemic Review of Biodegradable Nanomaterials in Nanomedicine · 2020
No notice
234.
Chai Z.; Hu X.; Wei X.; Zhan C.; Lu L.; Jiang K.; Su B.; Ruan H.; Ran D.; Fang R. H.; Zhang L.; Lu W. A Facile Approach to Functionalizing Cell Membrane-Coated Nanoparticles with Neurotoxin-Derived Peptide for Brain-Targeted Drug Delivery. J. Controlled Release 2017, 264, 102–111..
Not in our library10.1016/j.jconrel.2017.08.027
235.
Xu C.; Liu W.; Hu Y.; Li W.; Di W. Bioinspired Tumor-Homing Nanoplatform for Co-Delivery of Paclitaxel and siRNA-E7 to HPV-Related Cervical Malignancies for Synergistic Therapy. Theranostics 2020, 10, 3325–3339..
Not in our library10.7150/thno.41228
236.
Al-Nimry S.; Dayah A. A.; Hasan I.; Daghmash R. Cosmetic, Biomedical and Pharmaceutical Applications of Fish Gelatin/Hydrolysates. Mar. Drugs 2021, 19, 145–167..
Not in our library10.3390/md19030145
237.
Zhai Y.; Ran W.; Su J.; Lang T.; Meng J.; Wang G.; Zhang P.; Li Y. Traceable Bioinspired Nanoparticle for the Treatment of Metastatic Breast Cancer via NIR-Trigged Intracellular Delivery of Methylene Blue and Cisplatin. Adv. Mater. 2018, 30, 1802378–1802387..
Not in our library10.1002/adma.201802378
238.
Xie J.; Shen Q.; Huang K.; Zheng T.; Cheng L.; Zhang Z.; Yu Y.; Liao G.; Wang X.; Li C. Oriented Assembly of Cell-Mimicking Nanoparticles via a Molecular Affinity Strategy for Targeted Drug Delivery. ACS Nano 2019, 13, 5268–5277..
Not in our library10.1021/acsnano.8b09681
239.
He Y.; Li R.; Li H.; Zhang S.; Dai W.; Wu Q.; Jiang L.; Zheng Z.; Shen S.; Chen X.; Zhu Y.; Wang J.; Pang Z. Erythroliposomes: Integrated Hybrid Nanovesicles Composed of Erythrocyte Membranes and Artificial Lipid Membranes for Pore-Forming Toxin Clearance. ACS Nano 2019, 13, 4148–4159..
Not in our library10.1021/acsnano.8b08964
240.
Castro C. I.; Briceno J. C. Perfluorocarbon-Based Oxygen Carriers: Review of Products and Trials. Artif. Organs 2010, 34, 622–634..
Not in our library10.1111/j.1525-1594.2009.00944.x
241.
Lowe K. C. Blood Substitutes: From Chemistry to Clinic. J. Mater. Chem. 2006, 16, 4189–4196..
Not in our library10.1039/b604923k
242.
Gao M.; Liang C.; Song X.; Chen Q.; Jin Q.; Wang C.; Liu Z. Erythrocyte-Membrane-Enveloped Perfluorocarbon As Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy. Adv. Mater. 2017, 29, 1701429–1701435..
Not in our library10.1002/adma.201701429
243.
Zou M. Z.; Liu W. L.; Gao F.; Bai X. F.; Chen H. S.; Zeng X.; Zhang X. Z. Artificial Natural Killer Cells for Specific Tumor Inhibition and Renegade Macrophage Re-Education. Adv. Mater. 2019, 31, 1904495–1904504..
Not in our library10.1002/adma.201904495
244.
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer · 2017
No notice
245.
Carvalho G. C.; Sabio R. M.; de Cassia Ribeiro T.; Monteiro A. S.; Pereira D. V.; Ribeiro S. J. L.; Chorilli M. Highlights in Mesoporous Silica Nanoparticles As a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment. Pharm. Res. 2020, 37, 191–220..
Not in our library10.1007/s11095-020-02917-6
246.
Jafari S.; Derakhshankhah H.; Alaei L.; Fattahi A.; Varnamkhasti B. S.; Saboury A. A. Mesoporous Silica Nanoparticles for Therapeutic/Diagnostic Applications. Biomed. Pharmacother. 2019, 109, 1100–1111..
Not in our library10.1016/j.biopha.2018.10.167
247.
Cai D.; Liu L.; Han C.; Ma X.; Qian J.; Zhou J.; Zhu W. Cancer Cell Membrane-Coated Mesoporous Silica Loaded with Superparamagnetic Ferroferric Oxide and Paclitaxel for the Combination of Chemo/Magnetocaloric Therapy on MDA-MB-231 Cells. Sci. Rep. 2019, 9, 14475–14484..
Not in our library10.1038/s41598-019-51029-8
248.
Rastegari E.; Hsiao Y. J.; Lai W. Y.; Lai Y. H.; Yang T. C.; Chen S. J.; Huang P. I.; Chiou S. H.; Mou C. Y.; Chien Y. An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine. Pharmaceutics 2021, 13, 1067–1072..
Not in our library10.3390/pharmaceutics13071067
249.
Kersting M.; Olejnik M.; Rosenkranz N.; Loza K.; Breisch M.; Rostek A.; Westphal G.; Bunger J.; Ziegler N.; Ludwig A.; Koller M.; Sengstock C.; Epple M. Subtoxic Cell Responses to Silica Particles with Different Size and Shape. Sci. Rep. 2020, 10, 21591–21607..
Not in our library10.1038/s41598-020-78550-5
250.
Sen Karaman D.; Sarwar S.; Desai D.; Bjork E. M.; Oden M.; Chakrabarti P.; Rosenholm J. M.; Chakraborti S. Shape Engineering Boosts Antibacterial Activity of Chitosan Coated Mesoporous Silica Nanoparticle Doped with Silver: A Mechanistic Investigation. J. Mater. Chem. B 2016, 4, 3292–3304..
Not in our library10.1039/c5tb02526e
251.
Hao N.; Yang H.; Li L.; Li L.; Tang F. The Shape Effect of Mesoporous Silica Nanoparticles on Intracellular Reactive Oxygen Species in A375 Cells. New J. Chem. 2014, 38, 4258–4266..
Not in our library10.1039/c4nj00736k
252.
Natarajan S. K.; Selvaraj S. Mesoporous Silica Nanoparticles: Importance of Surface Modifications and its Role in Drug Delivery. RSC Adv. 2014, 4, 14328.
Not in our library10.1039/c4ra00781f
253.
Cook T. R.; Zheng Y. R.; Stang P. J. Metal-Organic Frameworks and Self-Assembled Supramolecular Coordination Complexes: Comparing and Contrasting the Design, Synthesis, and Functionality of Metal-Organic Materials. Chem. Rev. 2013, 113, 734–777..
Not in our library10.1021/cr3002824
254.
Hoop M.; Walde C. F.; Riccò R.; Mushtaq F.; Terzopoulou A.; Chen X.-Z.; deMello A. J.; Doonan C. J.; Falcaro P.; Nelson B. J.; Puigmartí-Luis J.; Pané S. Biocompatibility Characteristics of the Metal Organic Framework ZIF-8 for Therapeutical Applications. Appl. Mater. Today 2018, 11, 13–21..
Not in our library10.1016/j.apmt.2017.12.014
255.
Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives · 2018
No notice
256.
Zhang D.; Ye Z.; Wei L.; Luo H.; Xiao L. Cell Membrane-Coated Porphyrin Metal-Organic Frameworks for Cancer Cell Targeting and O2-Evolving Photodynamic Therapy. ACS Appl. Mater. Interfaces 2019, 11, 39594–39602..
Not in our library10.1021/acsami.9b14084
257.
Li S. Y.; Cheng H.; Xie B. R.; Qiu W. X.; Zeng J. Y.; Li C. X.; Wan S. S.; Zhang L.; Liu W. L.; Zhang X. Z. Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy. ACS Nano 2017, 11, 7006–7018..
Not in our library10.1021/acsnano.7b02533
258.
Li S. Y.; Cheng H.; Qiu W. X.; Zhang L.; Wan S. S.; Zeng J. Y.; Zhang X. Z. Cancer Cell Membrane-Coated Biomimetic Platform for Tumor Targeted Photodynamic Therapy and Hypoxia-Amplified Bioreductive Therapy. Biomaterials 2017, 142, 149–161..
Not in our library10.1016/j.biomaterials.2017.07.026
259.
Carnovale C.; Bryant G.; Shukla R.; Bansal V. Identifying Trends in Gold Nanoparticle Toxicity and Uptake: Size, Shape, Capping Ligand, and Biological Corona. ACS Omega 2019, 4, 242–256..
Not in our library10.1021/acsomega.8b03227
260.
Zhou C.; Long M.; Qin Y.; Sun X.; Zheng J. Luminescent Gold Nanoparticles with Efficient Renal Clearance. Angew. Chem., Int. Ed. 2011, 50, 3168–3172..
Not in our library10.1002/anie.201007321
261.
Jiang T.; Zhang B.; Shen S.; Tuo Y.; Luo Z.; Hu Y.; Pang Z.; Jiang X. Tumor Microenvironment Modulation by Cyclopamine Improved Photothermal Therapy of Biomimetic Gold Nanorods for Pancreatic Ductal Adenocarcinomas. ACS Appl. Mater. Interfaces 2017, 9, 31497–31508..
Not in our library10.1021/acsami.7b09458
262.
Rao L.; Bu L. L.; Ma L.; Wang W.; Liu H.; Wan D.; Liu J. F.; Li A.; Guo S. S.; Zhang L.; Zhang W. F.; Zhao X. Z.; Sun Z. J.; Liu W. Platelet-Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma. Angew. Chem., Int. Ed. 2018, 57, 986–991..
Not in our library10.1002/anie.201709457
263.
Li X.; Lovell J. F.; Yoon J.; Chen X. Clinical Development and Potential of Photothermal and Photodynamic Therapies for Cancer. Nat. Rev. Clin. Oncol. 2020, 17, 657–674..
Not in our library10.1038/s41571-020-0410-2
264.
Zou L.; Wang H.; He B.; Zeng L.; Tan T.; Cao H.; He X.; Zhang Z.; Guo S.; Li Y. Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics. Theranostics 2016, 6, 762–772..
Not in our library10.7150/thno.14988
265.
Ren X.; Zheng R.; Fang X.; Wang X.; Zhang X.; Yang W.; Sha X. Red Blood Cell Membrane Camouflaged Magnetic Nanoclusters for Imaging-Guided Photothermal Therapy. Biomaterials 2016, 92, 13–24..
Not in our library10.1016/j.biomaterials.2016.03.026
266.
Zhou Z.; Song J.; Nie L.; Chen X. Reactive Oxygen Species Generating Systems Meeting Challenges of Photodynamic Cancer Therapy. Chem. Soc. Rev. 2016, 45, 6597–6626..
Not in our library10.1039/c6cs00271d
267.
A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis · 2018
No notice
268.
Ding H.; Lv Y.; Ni D.; Wang J.; Tian Z.; Wei W.; Ma G. Erythrocyte Membrane-Coated NIR-Triggered Biomimetic Nanovectors with Programmed Delivery for Photodynamic Therapy of Cancer. Nanoscale 2015, 7, 9806–9815..
Not in our library10.1039/c5nr02470f
269.
Ren H.; Liu J.; Li Y.; Wang H.; Ge S.; Yuan A.; Hu Y.; Wu J. Oxygen Self-Enriched Nanoparticles Functionalized with Erythrocyte Membranes for Long Circulation and Enhanced Phototherapy. Acta Biomater. 2017, 59, 269–282..
Not in our library10.1016/j.actbio.2017.06.035
270.
Porphyrin‐Based Metal–Organic Frameworks for Biomedical Applications · 2020
No notice
271.
Bressler N. M. Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Two-Year Results of a Randomized Clinical Trial including Lesions with Occult with No Classic Choroidal Neovascularization—Verteporfin in Photodynamic Therapy Report 2. Am. J. Ophthalmol. 2001, 131, 541–560..
Not in our library10.1016/s0002-9394(01)00967-9
272.
Liu W.; Ruan M.; Wang Y.; Song R.; Ji X.; Xu J.; Dai J.; Xue W. Light-Triggered Biomimetic Nanoerythrocyte for Tumor-Targeted Lung Metastatic Combination Therapy of Malignant Melanoma. Small 2018, 14, 1801754–1801768..
Not in our library10.1002/smll.201801754
273.
Tapeinos C.; Tomatis F.; Battaglini M.; Larranaga A.; Marino A.; Telleria I. A.; Angelakeris M.; Debellis D.; Drago F.; Brero F.; Arosio P.; Lascialfari A.; Petretto A.; Sinibaldi E.; Ciofani G. Cell Membrane-Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act As a Versatile Theranostic System for Glioblastoma Multiforme. Adv. Healthcare Mater. 2019, 8, 1900612.
Not in our library10.1002/adhm.201900612
274.
Magnetic Nanomaterials as Contrast Agents for MRI · 2020
No notice
275.
Pan D.; Schmieder A. H.; Wickline S. A.; Lanza G. M. Manganese-Based MRI Contrast Agents: Past, Present and Future. Tetrahedron 2011, 67, 8431–8444..
Not in our library10.1016/j.tet.2011.07.076
276.
Tian Y.; Qiang S.; Wang L. Gold Nanomaterials for Imaging-Guided Near-Infrared in Vivo Cancer Therapy. Front. Bioeng. Biotechnol. 2019, 7, 398–406..
Not in our library10.3389/fbioe.2019.00398
277.
Rao L.; Meng Q. F.; Bu L. L.; Cai B.; Huang Q.; Sun Z. J.; Zhang W. F.; Li A.; Guo S. S.; Liu W.; Wang T. H.; Zhao X. Z. Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging. ACS Appl. Mater. Interfaces 2017, 9, 2159–2168..
Not in our library10.1021/acsami.6b14450
278.
Chen Y.; Zhang Y.; Chen M.; Zhuang J.; Fang R. H.; Gao W.; Zhang L. Biomimetic Nanosponges Suppress in Vivo Lethality Induced by the Whole Secreted Proteins of Pathogenic Bacteria. Small 2019, 15, 1804994–1805002..
Not in our library10.1002/smll.201804994
279.
Zhang Z.; Qian H.; Yang M.; Li R.; Hu J.; Li L.; Yu L.; Liu B.; Qian X. Gambogic Acid-Loaded Biomimetic Nanoparticles in Colorectal Cancer Treatment. Int. J. Nanomed. 2017, 12, 1593–1605..
Not in our library10.2147/ijn.s127256
280.
Yu Y.; Gao Y.; Yu Y. ″Waltz″ of Cell Membrane-Coated Nanoparticles on Lipid Bilayers: Tracking Single Particle Rotation in Ligand-Receptor Binding. ACS Nano 2018, 12, 11871–11880..
Not in our library10.1021/acsnano.8b04880
281.
Guo P.; Huang J.; Zhao Y.; Martin C. R.; Zare R. N.; Moses M. A. Nanomaterial Preparation by Extrusion through Nanoporous Membranes. Small 2018, 14, 1703493.
Not in our library10.1002/smll.201703493
282.
Evaluation of Extrusion Technique for Nanosizing Liposomes · 2016
No notice
283.
Charcosset C.; Limayem I.; Fessi H. The Membrane Emulsification Process—A Review. J. Chem. Technol. Biotechnol. 2004, 79, 209–218..
Not in our library10.1002/jctb.969
284.
Vladisavljevic G. T.; Williams R. A. Recent Developments in Manufacturing Emulsions and Particulate Products Using Membranes. Adv. Colloid Interface Sci. 2005, 113, 1–20..
Not in our library10.1016/j.cis.2004.10.002
285.
Maas M.; Guo P.; Keeney M.; Yang F.; Hsu T. M.; Fuller G. G.; Martin C. R.; Zare R. N. Preparation of Mineralized Nanofibers: Collagen Fibrils Containing Calcium Phosphate. Nano Lett. 2011, 11, 1383–1388..
Not in our library10.1021/nl200116d
286.
Gao W.; Hu C.-M. J.; Fang R. H.; Luk B. T.; Su J.; Zhang L. Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes. Adv. Mater. 2013, 25, 3549–3553..
Not in our library10.1002/adma.201300638
287.
Hayashi K.; Yamada S.; Sakamoto W.; Usugi E.; Watanabe M.; Yogo T. Red Blood Cell-Shaped Microparticles with a Red Blood Cell Membrane Demonstrate Prolonged Circulation Time in Blood. ACS Biomater. Sci. Eng. 2018, 4, 2729–2732..
Not in our library10.1021/acsbiomaterials.8b00197
288.
Arrigo R.; Teresi R.; Gambarotti C.; Parisi F.; Lazzara G.; Dintcheva N. T. Sonication-Induced Modification of Carbon Nanotubes: Effect on the Rheological and Thermo-Oxidative Behaviour of Polymer-Based Nanocomposites. Materials 2018, 11, 383–396..
Not in our library10.3390/ma11030383
289.
Rennhofer H.; Zanghellini B. Dispersion State and Damage of Carbon Nanotubes and Carbon Nanofibers by Ultrasonic Dispersion: A Review. Nanomaterials 2021, 11, 1469–1495..
Not in our library10.3390/nano11061469
290.
Sun H.; Yang B. In Situ Preparation of Nanoparticles/Polymer Composites. Sci. China, Ser. E: Technol. Sci. 2008, 51, 1886–1901..
Not in our library10.1007/s11431-008-0109-6
291.
Jia X.; Wang L.; Du J. In Situ Polymerization on Biomacromolecules for Nanomedicines. Nano Res. 2018, 11, 5028–5048..
Not in our library10.1007/s12274-018-2080-2
292.
Zhang J.; Gao W.; Fang R. H.; Dong A.; Zhang L. Synthesis of Nanogels via Cell Membrane-Templated Polymerization. Small 2015, 11, 4309–4313..
Not in our library10.1002/smll.201500987
293.
Kim K.; Lee W. G. Electroporation for Nanomedicine: A Review. J. Mater. Chem. B 2017, 5, 2726–2738..
Not in our library10.1039/c7tb00038c
294.
Behzadi S.; Serpooshan V.; Tao W.; Hamaly M. A.; Alkawareek M. Y.; Dreaden E. C.; Brown D.; Alkilany A. M.; Farokhzad O. C.; Mahmoudi M. Cellular Uptake of Nanoparticles: Journey Inside the Cell. Chem. Soc. Rev. 2017, 46, 4218–4244..
Not in our library10.1039/c6cs00636a
295.
Zhou X.; Luo B.; Kang K.; Zhang Y.; Jiang P.; Lan F.; Yi Q.; Wu Y. Leukocyte-Repelling Biomimetic Immunomagnetic Nanoplatform for High-Performance Circulating Tumor Cells Isolation. Small 2019, 15, 1900558–1900565..
Not in our library10.1002/smll.201900558
296.
Tu Y.; Lv M.; Xiu P.; Huynh T.; Zhang M.; Castelli M.; Liu Z.; Huang Q.; Fan C.; Fang H.; Zhou R. Destructive Extraction of Phospholipids from Escherichia Coli Membranes by Graphene Nanosheets. Nat. Nanotechnol. 2013, 8, 594–601..
Not in our library10.1038/nnano.2013.125
297.
Zhang C.; Liu W. L.; Bai X. F.; Cheng S. X.; Zhong Z. L.; Zhang X. Z. A Hybrid Nanomaterial with NIR-Induced Heat and Associated Hydroxyl Radical Generation for Synergistic Tumor Therapy. Biomaterials 2019, 199, 1–9..
Not in our library10.1016/j.biomaterials.2019.01.041
298.
Krishnamurthy S.; Gnanasammandhan M. K.; Xie C.; Huang K.; Cui M. Y.; Chan J. M. Monocyte Cell Membrane-Derived Nanoghosts for Targeted Cancer Therapy. Nanoscale 2016, 8, 6981–6895..
Not in our library10.1039/c5nr07588b
299.
Wu Z.; Li T.; Gao W.; Xu T.; Jurado-Sánchez B.; Li J.; Gao W.; He Q.; Zhang L.; Wang J. Cell-Membrane-Coated Synthetic Nanomotors for Effective Biodetoxification. Adv. Funct. Mater. 2015, 25, 3881–3887..
Not in our library10.1002/adfm.201501050
300.
Luk B. T.; Hu C. M.; Fang R. H.; Dehaini D.; Carpenter C.; Gao W.; Zhang L. Interfacial Interactions between Natural RBC Membranes and Synthetic Polymeric Nanoparticles. Nanoscale 2014, 6, 2730–2737..
Not in our library10.1039/c3nr06371b
301.
Saadatkhah N.; Carillo Garcia A.; Ackermann S.; Leclerc P.; Latifi M.; Samih S.; Patience G. S.; Chaouki J. Experimental Methods in Chemical Engineering: Thermogravimetric Analysis—TGA. Can. J. Chem. Eng. 2020, 98, 34–43..
Not in our library10.1002/cjce.23673
302.
Fan Z.; Zhou H.; Li P. Y.; Speer J. E.; Cheng H. Structural Elucidation of Cell Membrane-Derived Nanoparticles Using Molecular Probes. J. Mater. Chem. B 2014, 2, 8231–8238..
Not in our library10.1039/c4tb00980k
303.
Guo D.; Xie G.; Luo J. Mechanical Properties of Nanoparticles: Basics and Applications. J. Phys. D: Appl. Phys. 2014, 47, 013001–013025..
Not in our library10.1088/0022-3727/47/1/013001
304.
Ye H.; Shen Z.; Yu L.; Wei M.; Li Y. Manipulating Nanoparticle Transport within Blood Flow through External Forces: An Exemplar of Mechanics in Nanomedicine. Proc. R. Soc. London, Ser. A 2018, 474, 20170845–20170869..
Not in our library10.1098/rspa.2017.0845
305.
Hayashi K.; Yamada S.; Hayashi H.; Sakamoto W.; Yogo T. Red Blood Cell-Like Particles with the Ability to Avoid Lung and Spleen Accumulation for the Treatment of Liver Fibrosis. Biomaterials 2018, 156, 45–55..
Not in our library10.1016/j.biomaterials.2017.11.031
306.
Kang Y. J.; Ha Y.-R.; Lee S.-J. Deformability Measurement of Red Blood Cells Using a Microfluidic Channel Array and an Air Cavity in a Driving Syringe with High Throughput and Precise Detection of Subpopulations. Analyst 2016, 141, 319–330..
Not in our library10.1039/c5an01988e
307.
Mohd Noor A.; Masuda T.; Arai F. Microfluidic Device for Rapid Investigation of the Deformability of Leukocytes in Whole Blood Samples. ROBOMECH J. 2020, 7, 5–15..
Not in our library10.1186/s40648-019-0153-y
308.
Yang N.; Ding Y.; Zhang Y.; Wang B.; Zhao X.; Cheng K.; Huang Y.; Taleb M.; Zhao J.; Dong W. F.; Zhang L.; Nie G. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy. ACS Appl. Mater. Interfaces 2018, 10, 22963–22973..
Not in our library10.1021/acsami.8b05363
309.
Su J.; Sun H.; Meng Q.; Yin Q.; Tang S.; Zhang P.; Chen Y.; Zhang Z.; Yu H.; Li Y. Long Circulation Red-Blood-Cell-Mimetic Nanoparticles with Peptide-Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer. Adv. Funct. Mater. 2016, 26, 1243–1252..
Not in our library10.1002/adfm.201504780
310.
Song Y.; Huang Z.; Liu X.; Pang Z.; Chen J.; Yang H.; Zhang N.; Cao Z.; Liu M.; Cao J.; Li C.; Yang X.; Gong H.; Qian J.; Ge J. Platelet Membrane-Coated Nanoparticle-Mediated Targeting Delivery of Rapamycin Blocks Atherosclerotic Plaque Development and Stabilizes Plaque in Apolipoprotein E-Deficient (ApoE(−/−)) Mice. Nanomedicine 2019, 15, 13–24..
Not in our library10.1016/j.nano.2018.08.002
311.
Aslam B.; Basit M.; Nisar M. A.; Khurshid M.; Rasool M. H. Proteomics: Technologies and Their Applications. J. Chromatogr. Sci. 2017, 55, 182–196..
Not in our library10.1093/chromsci/bmw167
312.
Li R.; He Y.; Zhu Y.; Jiang L.; Zhang S.; Qin J.; Wu Q.; Dai W.; Shen S.; Pang Z.; Wang J. Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles. Nano Lett. 2019, 19, 124–134..
Not in our library10.1021/acs.nanolett.8b03439
313.
Li H.; Jin K.; Luo M.; Wang X.; Zhu X.; Liu X.; Jiang T.; Zhang Q.; Wang S.; Pang Z. Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles. Cells 2019, 8, 881–896..
Not in our library10.3390/cells8080881
314.
The immune system in cancer metastasis: friend or foe? · 2017
No notice
315.
Shihab I.; Khalil B. A.; Elemam N. M.; Hachim I. Y.; Hachim M. Y.; Hamoudi R. A.; Maghazachi A. A. Understanding the Role of Innate Immune Cells and Identifying Genes in Breast Cancer Microenvironment. Cancers 2020, 12, 2226–2241..
Not in our library10.3390/cancers12082226
316.
Azevedo A. S.; Follain G.; Patthabhiraman S.; Harlepp S.; Goetz J. G. Metastasis of Circulating Tumor Cells: Favorable Soil or Suitable Biomechanics, or Both?. Cell Adh Migr 2015, 9, 345–356..
Not in our library10.1080/19336918.2015.1059563
317.
Micalizzi D. S.; Maheswaran S.; Haber D. A. A Conduit to Metastasis: Circulating Tumor Cell Biology. Genes Dev. 2017, 31, 1827–1840..
Not in our library10.1101/gad.305805.117
318.
Grigor E. J. M.; Fergusson D.; Kekre N.; Montroy J.; Atkins H.; Seftel M. D.; Daugaard M.; Presseau J.; Thavorn K.; Hutton B.; Holt R. A.; Lalu M. M. Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis. Transfus. Med. Rev. 2019, 33, 98–110..
Not in our library10.1016/j.tmrv.2019.01.005
319.
Feins S.; Kong W.; Williams E. F.; Milone M. C.; Fraietta J. A. An Introduction to Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy for Human Cancer. Am. J. Hematol. 2019, 94, S3–S9..
Not in our library10.1002/ajh.25418
320.
Restifo N. P.; Dudley M. E.; Rosenberg S. A. Adoptive Immunotherapy for Cancer: Harnessing the T Cell Response. Nat. Rev. Immunol. 2012, 12, 269–281..
Not in our library10.1038/nri3191
321.
Maus M. V.; Fraietta J. A.; Levine B. L.; Kalos M.; Zhao Y.; June C. H. Adoptive Immunotherapy for Cancer or Viruses. Annu. Rev. Immunol. 2014, 32, 189–225..
Not in our library10.1146/annurev-immunol-032713-120136
322.
A decade of immune-checkpoint inhibitors in cancer therapy · 2020
No notice
323.
Hargadon K. M.; Johnson C. E.; Williams C. J. Immune Checkpoint Blockade Therapy for Cancer: An Overview of FDA-Approved Immune Checkpoint Inhibitors. Int. Immunopharmacol. 2018, 62, 29–39..
Not in our library10.1016/j.intimp.2018.06.001
324.
Schirrmacher V. Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients Than Other Systemic Therapies: A Comparative Analysis. Biomedicines 2020, 8, 61–80..
Not in our library10.3390/biomedicines8030061
325.
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment · 2020
No notice
326.
Monoclonal Antibodies in Cancer Therapy · 2020
No notice
327.
Cytokines in clinical cancer immunotherapy · 2018
No notice
328.
Matsushita M.; Kawaguchi M. Immunomodulatory Effects of Drugs for Effective Cancer Immunotherapy. J. Oncol. 2018, 2018, 8653489–8653495..
Not in our library10.1155/2018/8653489
329.
Restifo N. P.; Smyth M. J.; Snyder A. Acquired Resistance to Immunotherapy and Future Challenges. Nat. Rev. Cancer 2016, 16, 121–126..
Not in our library10.1038/nrc.2016.2
330.
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome · 2017
No notice
331.
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates · 2019
No notice
332.
Chen H.; Sha H.; Zhang L.; Qian H.; Chen F.; Ding N.; Ji L.; Zhu A.; Xu Q.; Meng F.; Yu L.; Zhou Y.; Liu B. Lipid Insertion Enables Targeted Functionalization of Paclitaxel-Loaded Erythrocyte Membrane Nanosystem by Tumor-Penetrating Bispecific Recombinant Protein. Int. J. Nanomed. 2018, 13, 5347–5359..
Not in our library10.2147/ijn.s165109
333.
Chai Z.; Ran D.; Lu L.; Zhan C.; Ruan H.; Hu X.; Xie C.; Jiang K.; Li J.; Zhou J.; Wang J.; Zhang Y.; Fang R. H.; Zhang L.; Lu W. Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano 2019, 13, 5591–5601..
Not in our library10.1021/acsnano.9b00661
334.
Kang T.; Jiang M.; Jiang D.; Feng X.; Yao J.; Song Q.; Chen H.; Gao X.; Chen J. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Mol. Pharmaceutics 2015, 12, 2947–2961..
Not in our library10.1021/acs.molpharmaceut.5b00222
335.
Fu S.; Liang M.; Wang Y.; Cui L.; Gao C.; Chu X.; Liu Q.; Feng Y.; Gong W.; Yang M.; Li Z.; Yang C.; Xie X.; Yang Y.; Gao C. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. ACS Appl. Mater. Interfaces 2019, 11, 1841–1854..
Not in our library10.1021/acsami.8b18664
336.
Huang N.; Cheng S.; Zhang X.; Tian Q.; Pi J.; Tang J.; Huang Q.; Wang F.; Chen J.; Xie Z.; Xu Z.; Chen W.; Zheng H.; Cheng Y. Efficacy of NGR Peptide-Modified PEGylated Quantum Dots for Crossing the Blood-Brain Barrier and Targeted Fluorescence Imaging of Glioma and Tumor Vasculature. Nanomedicine 2017, 13, 83–93..
Not in our library10.1016/j.nano.2016.08.029
337.
Dunne M.; Zheng J.; Rosenblat J.; Jaffray D. A.; Allen C. APN/CD13-Targeting As a Strategy to Alter the Tumor Accumulation of Liposomes. J. Controlled Release 2011, 154, 298–305..
Not in our library10.1016/j.jconrel.2011.05.022
338.
Ding D.; Yao Y.; Zhang S.; Su C.; Zhang Y. C-Type Lectins Facilitate Tumor Metastasis. Oncol. Lett. 2017, 13, 13–21..
Not in our library10.3892/ol.2016.5431
339.
Hu Q.; Sun W.; Qian C.; Wang C.; Bomba H. N.; Gu Z. Anticancer Platelet-Mimicking Nanovehicles. Adv. Mater. 2015, 27, 7043–7050..
Not in our library10.1002/adma.201503323
340.
Yuan X.; Gajan A.; Chu Q.; Xiong H.; Wu K.; Wu G. S. Developing TRAIL/TRAIL Death Receptor-Based Cancer Therapies. Cancer Metastasis Rev. 2018, 37, 733–748..
Not in our library10.1007/s10555-018-9728-y
341.
Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics · 2020
Not checked
342.
Cheng H.; Zhu J.-Y.; Li S.-Y.; Zeng J.-Y.; Lei Q.; Chen K.-W.; Zhang C.; Zhang X.-Z. An O2 Self-Sufficient Biomimetic Nanoplatform for Highly Specific and Efficient Photodynamic Therapy. Adv. Funct. Mater. 2016, 26, 7847–7860..
Not in our library10.1002/adfm.201603212
343.
Yang R.; Xu J.; Xu L.; Sun X.; Chen Q.; Zhao Y.; Peng R.; Liu Z. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination. ACS Nano 2018, 12, 5121–5129..
Not in our library10.1021/acsnano.7b09041
344.
Howells A.; Marelli G.; Lemoine N. R.; Wang Y. Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer. Front. Oncol. 2017, 7, 195–209..
Not in our library10.3389/fonc.2017.00195
345.
Noy R.; Pollard J. W. Tumor-Associated Macrophages: From Mechanisms to Therapy. Immunity 2014, 41, 49–61..
Not in our library10.1016/j.immuni.2014.06.010
346.
Qian B. Z.; Pollard J. W. Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell 2010, 141, 39–51..
Not in our library10.1016/j.cell.2010.03.014
347.
Wan L.; Pantel K.; Kang Y. Tumor Metastasis: Moving New Biological Insights into the Clinic. Nat. Med. 2013, 19, 1450–1464..
Not in our library10.1038/nm.3391
348.
Chen Q.; Zhang X. H.; Massague J. Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells That Invade the Lungs. Cancer Cell 2011, 20, 538–549..
Not in our library10.1016/j.ccr.2011.08.025
349.
Jablonska J.; Lang S.; Sionov R. V.; Granot Z. The Regulation of Pre-Metastatic Niche Formation by Neutrophils. Oncotarget 2017, 8, 112132–112144..
Not in our library10.18632/oncotarget.22792
350.
Wu M.; Ma M.; Tan Z.; Zheng H.; Liu X. Neutrophil: A New Player in Metastatic Cancers. Front. Immunol. 2020, 11, 565165–565178..
Not in our library10.3389/fimmu.2020.565165
351.
De Miguel M. P.; Julián S. F.; Blázquez-Martínez A.; Pascual C. Y.; Aller M. A.; Arias J.; Arnalich-Montiel F. Immunosuppressive Properties of Mesenchymal Stem Cells: Advances and Applications. Curr. Mol. Med. 2012, 12, 574–591..
Not in our library10.2174/156652412800619950
352.
Li L.; Guan Y.; Liu H.; Hao N.; Liu T.; Meng X.; Fu C.; Li Y.; Qu Q.; Zhang Y.; Ji S.; Chen L.; Chen D.; Tang F. Silica Nanorattle-Doxorubicin Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy. ACS Nano 2011, 5, 7462–7470..
Not in our library10.1021/nn202399w
353.
Wei X.; Yang X.; Han Z. P.; Qu F. F.; Shao L.; Shi Y. F. Mesenchymal Stem Cells: A New Trend for Cell Therapy. Acta Pharmacol. Sin. 2013, 34, 747–754..
Not in our library10.1038/aps.2013.50
354.
Apetoh L.; Ladoire S.; Coukos G.; Ghiringhelli F. Combining Immunotherapy and Anticancer Agents: The Right Path to Achieve Cancer Cure?. Ann. Oncol. 2015, 26, 1813–1823..
Not in our library10.1093/annonc/mdv209
355.
Howard C. J.; Charleston B.; Stephens S. A.; Sopp P.; Hope J. C. The Role of Dendritic Cells in Shaping the Immune Response. Anim. Health Res. Rev. 2004, 5, 191–195..
Not in our library10.1079/ahr200468
356.
Kantoff P. W.; Higano C. S.; Shore N. D.; Berger E. R.; Small E. J.; Penson D. F.; Redfern C. H.; Ferrari A. C.; Dreicer R.; Sims R. B.; Xu Y.; Frohlich M. W.; Schellhammer P. F. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. N. Engl. J. Med. 2010, 363, 411–422..
Not in our library10.1056/nejmoa1001294
357.
Dendritic Cell Vaccines in Ovarian Cancer · 2021
Not checked
358.
Ovarian Cancer Immunotherapy: Turning up the Heat · 2019
No notice
359.
Guo Q.; Yang Q.; Li J.; Liu G.; Nikoulin I.; Jia S. Advanced Clinical Trials of Dendritic Cell Vaccines in Ovarian Cancer. J. Invest. Med. 2020, 68, 1223–1227..
Not in our library10.1136/jim-2020-001355
360.
Cubillos-Ruiz J. R.; Silberman P. C.; Rutkowski M. R.; Chopra S.; Perales-Puchalt A.; Song M.; Zhang S.; Bettigole S. E.; Gupta D.; Holcomb K.; Ellenson L. H.; Caputo T.; Lee A. H.; Conejo-Garcia J. R.; Glimcher L. H. ER Stress Sensor XBP1 Controls Anti-Tumor Immunity by Disrupting Dendritic Cell Homeostasis. Cell 2015, 161, 1527–1538..
Not in our library10.1016/j.cell.2015.05.025
361.
Cintolo J. A.; Datta J.; Mathew S. J.; Czerniecki B. J. Dendritic Cell-Based Vaccines: Barriers and Opportunities. Future Oncol. 2012, 8, 1273–1299..
Not in our library10.2217/fon.12.125
362.
O’Neill L. A.; Pearce E. J. Immunometabolism Governs Dendritic Cell and Macrophage Function. J. Exp. Med. 2016, 213, 15–23..
Not in our library10.1084/jem.20151570
363.
Chen B.; Dai W.; Mei D.; Liu T.; Li S.; He B.; He B.; Yuan L.; Zhang H.; Wang X.; Zhang Q. Comprehensively Priming the Tumor Microenvironment by Cancer-Associated Fibroblast-Targeted Liposomes for Combined Therapy with Cancer Cell-Targeted Chemotherapeutic Drug Delivery System. J. Controlled Release 2016, 241, 68–80..
Not in our library10.1016/j.jconrel.2016.09.014
364.
Ji T.; Ding Y.; Zhao Y.; Wang J.; Qin H.; Liu X.; Lang J.; Zhao R.; Zhang Y.; Shi J.; Tao N.; Qin Z.; Nie G. Peptide Assembly Integration of Fibroblast-Targeting and Cell-Penetration Features for Enhanced Antitumor Drug Delivery. Adv. Mater. 2015, 27, 1865–1873..
Not in our library10.1002/adma.201404715
365.
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response · 2017
No notice
366.
Fan J. X.; Li Z. H.; Liu X. H.; Zheng D. W.; Chen Y.; Zhang X. Z. Bacteria-Mediated Tumor Therapy Utilizing Photothermally-Controlled TNF-alpha Expression via Oral Administration. Nano Lett. 2018, 18, 2373–2380..
Not in our library10.1021/acs.nanolett.7b05323
367.
Lee J.; Yoon Y. J.; Kim J. H.; Dinh N. T. H.; Go G.; Tae S.; Park K. S.; Park H. T.; Lee C.; Roh T. Y.; Di Vizio D.; Gho Y. S. Outer Membrane Vesicles Derived from Escherichia coli Regulate Neutrophil Migration by Induction of Endothelial IL-8. Front. Microbiol. 2018, 9, 2268–2279..
Not in our library10.3389/fmicb.2018.02268
368.
Karin M.; Clevers H. Reparative Inflammation Takes Charge of Tissue Regeneration. Nature 2016, 529, 307–315..
Not in our library10.1038/nature17039
369.
Modulation of the Inflammatory Response and Bone Healing · 2020
No notice
370.
Su Y.; Gao J.; Kaur P.; Wang Z. Neutrophils and Macrophages As Targets for Development of Nanotherapeutics in Inflammatory Diseases. Pharmaceutics 2020, 12, 1222–1245..
Not in our library10.3390/pharmaceutics12121222
371.
Luster A. D.; Alon R.; von Andrian U. H. Immune Cell Migration in Inflammation: Present and Future Therapeutic Targets. Nat. Immunol. 2005, 6, 1182–1190..
Not in our library10.1038/ni1275
372.
Goldberg I. J.; Sharma G.; Fisher E. A. Atherosclerosis: Making a U Turn. Annu. Rev. Med. 2020, 71, 191–201..
Not in our library10.1146/annurev-med-042418-011108
373.
Byrne R. A.; Joner M.; Kastrati A. Stent Thrombosis and Restenosis: What Have We Learned and Where are We Going? The Andreas Gruntzig Lecture ESC 2014. Eur. Heart J. 2015, 36, 3320–3331..
Not in our library10.1093/eurheartj/ehv511
374.
Cardiovascular stents: overview, evolution, and next generation · 2018
No notice
375.
Nording H.; Baron L.; Langer H. F. Platelets As Therapeutic Targets to Prevent Atherosclerosis. Atherosclerosis 2020, 307, 97–108..
Not in our library10.1016/j.atherosclerosis.2020.05.018
376.
von Hundelshausen P.; Schmitt M. M. Platelets and Their Chemokines in Atherosclerosis-Clinical Applications. Front. Physiol. 2014, 5, 294–310..
Not in our library10.3389/fphys.2014.00294
377.
Wu M. D.; Atkinson T. M.; Lindner J. R. Platelets and Von Willebrand Factor in Atherogenesis. Blood 2017, 129, 1415–1419..
Not in our library10.1182/blood-2016-07-692673
378.
Langer H.; Gawaz M. Platelet-Vessel Wall Interactions in Atherosclerotic Disease. Thromb. Haemostasis 2008, 99, 480–486..
Not in our library10.1160/th07-11-0685
379.
Albakri A. Ischemic Heart Failure: A Review of Clinical Status and Meta-analysis of Diagnosis and Clinical Management Methods. Clin Med. Investig 2018, 3, 1–15..
Not in our library10.15761/cmi.1000171
380.
Enhancing the Migration Ability of Mesenchymal Stromal Cells by Targeting the SDF-1/CXCR4 Axis · 2013
No notice
381.
Jeong H.; Yim H. W.; Park H. J.; Cho Y.; Hong H.; Kim N. J.; Oh I. H. Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis. Int. J. Stem Cells 2018, 11, 1–12..
Not in our library10.15283/ijsc17061
382.
Arshad M. A.; Murphy N.; Bangash M. N. Acute Liver Failure. Clin. Med. 2020, 20, 505–508..
Not in our library10.7861/clinmed.2020-0612
383.
Nicolas C.; Wang Y.; Luebke-Wheeler J.; Nyberg S. L. Stem Cell Therapies for Treatment of Liver Disease. Biomedicines 2016, 4, 907–910..
Not in our library10.3390/biomedicines4010002
384.
Crop M. J.; Baan C. C.; Korevaar S. S.; Ijzermans J. N.; Pescatori M.; Stubbs A. P.; van Ijcken W. F.; Dahlke M. H.; Eggenhofer E.; Weimar W.; Hoogduijn M. J. Inflammatory Conditions Affect Gene Expression and Function of Human Adipose Tissue-derived Mesenchymal Stem Cells. Clin. Exp. Immunol. 2010, 162, 474–486..
Not in our library10.1111/j.1365-2249.2010.04256.x
385.
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion · 2012
No notice
386.
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis · 2020
No notice
387.
Burmester G. R.; Feist E.; Dorner T. Emerging Cell and Cytokine Targets in Rheumatoid Arthritis. Nat. Rev. Rheumatol. 2014, 10, 77–88..
Not in our library10.1038/nrrheum.2013.168
388.
Wipke B. T.; Allen P. M. Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis. J. Immunol. 2001, 167, 1601–1608..
Not in our library10.4049/jimmunol.167.3.1601
389.
Headland S. E.; Jones H. R.; Norling L. V.; Kim A.; Souza P. R.; Corsiero E.; Gil C. D.; Nerviani A.; Dell’Accio F.; Pitzalis C.; Oliani S. M.; Jan L. Y.; Perretti M. Neutrophil-Derived Microvesicles Enter Cartilage and Protect the Joint in Inflammatory Arthritis. Sci. Transl. Med. 2015, 7, 315ra190.
Not in our library10.1126/scitranslmed.aac5608
390.
Kremer J. M.; Westhovens R.; Leon M.; Di Giorgio E.; Alten R.; Steinfeld S.; Russell A.; Dougados M.; Emery P.; Nuamah I. F.; Williams G. R.; Becker J.-C.; Hagerty D. T.; Moreland L. W. Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig. N. Engl. J. Med. 2003, 349, 1907–1915..
Not in our library10.1056/nejmoa035075
391.
McInnes I. B.; Schett G. Cytokines in the Pathogenesis of Rheumatoid Arthritis. Nat. Rev. Immunol. 2007, 7, 429–442..
Not in our library10.1038/nri2094
392.
Kirtane A. R.; Verma M.; Karandikar P.; Furin J.; Langer R.; Traverso G. Nanotechnology Approaches for Global Infectious Diseases. Nat. Nanotechnol. 2021, 16, 369–384..
Not in our library10.1038/s41565-021-00866-8
393.
Van der Meer J. W. The Infectious Disease Challenges of our Time. Front. Public Health 2013, 1, 1–2..
Not in our library10.3389/fpubh.2013.00007
394.
Gamblin S. J.; Skehel J. J. Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins. J. Biol. Chem. 2010, 285, 28403–28409..
Not in our library10.1074/jbc.r110.129809
395.
Siboo I. R.; Chambers H. F.; Sullam P. M. Role of SraP, a Serine-Rich Surface Protein of Staphylococcus Aureus, in Binding to Human Platelets. Infect. Immun. 2005, 73, 2273–2280..
Not in our library10.1128/iai.73.4.2273-2280.2005
396.
Effective treatment of severe COVID-19 patients with tocilizumab · 2020
No notice
397.
Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines · 2020
No notice
398.
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 · 2020
No notice
399.
Qi F.; Qian S.; Zhang S.; Zhang Z. Single Cell RNA Sequencing of 13 Human Tissues Identify Cell Types and Receptors of Human Coronaviruses. Biochem. Biophys. Res. Commun. 2020, 526, 135–140..
Not in our library10.1016/j.bbrc.2020.03.044
400.
Zhang Q.; Honko A.; Zhou J.; Gong H.; Downs S. N.; Vasquez J. H.; Fang R. H.; Gao W.; Griffiths A.; Zhang L. Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity. Nano Lett. 2020, 20, 5570–5574..
Not in our library10.1021/acs.nanolett.0c02278
401.
Liu Y.; Liu J.; Du S.; Shan C.; Nie K.; Zhang R.; Li X. F.; Zhang R.; Wang T.; Qin C. F.; Wang P.; Shi P. Y.; Cheng G. Evolutionary Enhancement of Zika Virus Infectivity in Aedes Aegypti Mosquitoes. Nature 2017, 545, 482–486..
Not in our library10.1038/nature22365
402.
Wang L.; Valderramos S. G.; Wu A.; Ouyang S.; Li C.; Brasil P.; Bonaldo M.; Coates T.; Nielsen-Saines K.; Jiang T.; Aliyari R.; Cheng G. From Mosquitos to Humans: Genetic Evolution of Zika Virus. Cell Host Microbe 2016, 19, 561–565..
Not in our library10.1016/j.chom.2016.04.006
403.
Platt D. J.; Smith A. M.; Arora N.; Diamond M. S.; Coyne C. B.; Miner J. J. Zika Virus-Related Neurotropic Flaviviruses Infect Human Placental Explants and Cause Fetal Demise in Mice. Sci. Transl. Med. 2018, 10, eaao7090.
Not in our library10.1126/scitranslmed.aao7090
404.
Yan M.; Luan R. Research Progress of the Causal Link between Zika Virus and Microcephaly. Glob. Health J. 2018, 2, 11–18..
Not in our library10.1016/s2414-6447(19)30178-2
405.
Kreuter J. Nanoparticulate Systems for Brain Delivery of Drugs. Adv. Drug Delivery Rev. 2001, 47, 65–81..
Not in our library10.1016/s0169-409x(00)00122-8
406.
Campbell E. M.; Hope T. J. HIV-1 Capsid: The Multifaceted Key Player in HIV-1 Infection. Nat. Rev. Microbiol. 2015, 13, 471–483..
Not in our library10.1038/nrmicro3503
407.
Los F. C.; Randis T. M.; Aroian R. V.; Ratner A. J. Role of Pore-Forming Toxins in Bacterial Infectious Diseases. Microbiol. Mol. Biol. Rev. 2013, 77, 173–207..
Not in our library10.1128/mmbr.00052-12
408.
Jing L.; Qu H.; Wu D.; Zhu C.; Yang Y.; Jin X.; Zheng J.; Shi X.; Yan X.; Wang Y. Platelet-Camouflaged Nanococktail: Simultaneous Inhibition of Drug-Resistant Tumor Growth and Metastasis via a Cancer Cells and Tumor Vasculature Dual-Targeting Strategy. Theranostics 2018, 8, 2683–2695..
Not in our library10.7150/thno.23654
409.
Copp J. A.; Fang R. H.; Luk B. T.; Hu C. M.; Gao W.; Zhang K.; Zhang L. Clearance of Pathological Antibodies Using Biomimetic Nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 2014, 111, 13481–13486..
Not in our library10.1073/pnas.1412420111
410.
Lv W.; Xu J.; Wang X.; Li X.; Xu Q.; Xin H. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles As Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment. ACS Nano 2018, 12, 5417–5426..
Not in our library10.1021/acsnano.8b00477
411.
Hassan M.; Yazid M. D.; Yunus M. H. M.; Chowdhury S. R.; Lokanathan Y.; Idrus R. B. H.; Ng A. M. H.; Law J. X. Large-Scale Expansion of Human Mesenchymal Stem Cells. Stem Cells Int. 2020, 2020, 9529465–9529281..
Not in our library10.1155/2020/9529465
412.
Meng Y.; Sun J.; Hu T.; Ma Y.; Du T.; Kong C.; Zhang G.; Yu T.; Piao H. Rapid Expansion in the WAVE Bioreactor of Clinical Scale Cells for Tumor Immunotherapy. Hum. Vaccines Immunother. 2018, 14, 2516–2526..
Not in our library10.1080/21645515.2018.1480241
413.
Coeshott C.; Vang B.; Jones M.; Nankervis B. Large-Scale Expansion and Characterization of CD3 (+) T-cells in the Quantum® Cell Expansion System. J. Transl. Med. 2019, 17, 258–270..
Not in our library10.1186/s12967-019-2001-5
414.
Stephenson M.; Grayson W. Recent Advances in Bioreactors for Cell-Based Therapies. F1000Research 2018, 7, 517–525..
Not in our library10.12688/f1000research.12533.1
415.
Bjij I.; Khan S.; Ramharak P.; Cherqaoui D.; Soliman M. E. S. Distinguishing the Optimal Binding Mechanism of an E3 Ubiquitin Ligase: Covalent Versus Non Covalent Inhibition. J. Cell. Biochem. 2019, 120, 12859–12869..
Not in our library10.1002/jcb.28556

Cited by papers we hold 2

Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier · 2025
Not checked
Cell membrane-coated nanoparticles: An emerging antibacterial platform for pathogens of food animals · 2023
Not checked

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.